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I
Abstract: The synthesis of various cyclica-hydrazino esters is described. The key-step involves an intramolecular 
reaction of a highly reactive A^acvlhydiazonium ion, leading to a cyclic cationic intermediate which either rearranges via 
an aziridinium ion, or leads to the unrearranged piperazic ester. A deprotection sequence that furnishes the tree a~ 
hydrazino acids is detailed.
INTRODUCTION
Since the first discovery three decades ago,1 various tetra- and hexahydro-3-pyridazinecarboxylic acids, 
or piperazic acids (Piz) have been isolated. As constituents of several biologically active peptides such as the 
cyclic peptides monamycin,2 L-156,6023 and luzopeptin A,4 the acyclic antrimycins,5 cirratiomycins,6 
azinothricin antitumor antibiotics? and the recently discovered antibiotic mathlystadn these compounds
T
constitute a novel subclass of cyclic amino acids. Some of the piperazic acids present in these pepddes are 
shown below.
1 R = R' =* H 4 R = H
2R = H,R’ = OH 5 R =* OH
3 R -  Cl, R’ « H
The resemblance of these types of molecules with the corresponding a-amino acids suggests a 
promising potential as pharmacologically important compounds.9*10 Recendy, several syntheses of cyclic 
hydrazino acids were reported among which piperazic acid 2 was synthesized via a hetero Diels-Alder reaction 
of a dienophile with an azo compound.11 Furthermore, the acids 1, 4 and 5 were obtained via intramolecular 
condensations of enantiopure 2-hydraz}no-5-oxo-pentanoic esters,12-15 the latter being prepared by 
enantioselective a-amination of enolates with an azodicarboxylate.16
» •
Herein, we wish to report a novel approach to the synthesis of (racemic) cyclic a-hydrazino acids, 
which extends our previously reported work on Af-acylhydrazonium ion cyclizations.17 for example, a 
sequence that is expected to lead to the chlorine substituted a-hydrazino acid 3 involves ring closure of 8 via the 
N-acylhydrazonium ion 7 to the protected a-hydrazino acid 6 (eq 1).
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CO^Mb CO2M9
6 7 8 9
Comparison with well-investigated N-acyliminium ion cyclizations1 8 leads to the expectation that the 
cationic intermediate 7 will adopt a chair-like conformation, in which the N-acyli minium part has a (Z)- 
geometry. The preference for this geometry can be understood by considering the two possible conformations A 
and B of the hydrazonium ion. The (E)-isomer B is likely to be less stable as a result of pseudo-ohylic 1,3- 
strain19 between the two carbonyl functions, which is absent in the (2)-isomer A.
J
ROzCs+.N^ H O A + ^N ^
x
H CQ2M0 Me02C
A B
Attack of a nucleophile (e.g. chloride) on the intermediate 75-cocnplex of the olefin with the iminium ion 
will result in an overall, flnoHJ-addition to the double bond, leading to the desired frmf-relationship between the 
substituents in compound 6 . The free hydrazine 3 might be obtained by deprotection of 6 , in which R and R* 
are appropriate functional groups. The cyclization precursor 8 will be prepared from the suitably functionalized 
hydrazine 9 by alkylation with allyl bromide and methyl glyoxylate, respectively.
Moreover, introduction of various nucleophilic side chains will be shown to lead to the synthesis of 
numerous functionalized cyclic a-hydrazino acids of different ring sizes.
RESULTS AND DISCUSSION
The benzyl and allyloxycarbonyl (Alloc)20 function were considered to be proper groups to functionalize 
both nitrogen atoms. In order to obtain the desired starting material 12, an excess of hydrazine hydrate was 
treated at -20 "C with allyl chlaroformate to give allyl carbazate 10 (eq 2),21 which was readily purified by 
distillation. At lower temperatures, the reaction did not proceed whereas at higher temperatures the diacylated 
product was obtained. Because straightforward alkylation of 10 with benzyl chloride mainly led to dibenzylation 
of ally! carbazate (1 0 ), an alternative route was chosen for the synthesis of the monobenzylated carbazate 1 2 .
Ph 1) NaBH3CN, Ph
AUylOiCCl, J pTSA J
NHZ K2CO3, yha PhCHO, f  THF, it HN
NHj-HjO ------------ - Alln^ NH ---------- - AI1_^NH ------------------ NH (e£l 2)
EtOH, All0C toluene, rt ™  2)lNNaOH,rt
-20 'C -» rt 10(77%) 11(94%) 12(99%)
Thus, allyl carbazate (10) was condensed with benzaldehyde to give the hydrazone 11, which was 
reduced with NaBH^CN to give 12 as its cyanoborane complex.22 Hydrolysis of the complex with NaOH 
afforded the monobenzylated carbazate 12. Distillation of 12 led to a dramatic decrease of the yield, so that 
crude 12 (virtually pure according to ^H NMR data) was used for further reactions.
The functionalized hydrazine 12 was alkylated at the nucleophilic benzylic nitrogen atom with various 
halides as summarized in Table I {halide (1.1 equiv), K2CO3 (1.2 equiv), Lil (cat), butanone, acetone or 
ethanol, reflux). In general, reasonable to good yields were obtained for the activated halides. The less reactive 
butenyl bromide gave a lower yield (entry 8). Surprisingly, reaction of 12 with 4-iodo-1 -(trimethylsilyl)-2- 
butyne2*^ 24 under refluxing conditions led to desilylation of the propargylsilane moiety so that the allene 17 was
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formed in a rather low yield (entry 7). At room temperature, however, the desired propargylsilane 21 was 
formed (entry 12). The (E)-vinylsilane 22 (entry 13) was obtained upon alkylation of 12 with (E)-3-bromo-l- 
(trimethylsilyl)-1 -propene25 »^ 6 while the 1:1.9 (£)/(Z) mixture of vinylsilanes 23 (entry 13) was obtained by 
alkylation of 12 with a 1:2.5 (Ey(Z>mixture of 3-bromo-l-(trimethyteilyl)-l-propene.26'28
Introduction of the glyoxylate moiety was performed by stirring the alkylation product in the presence of 
anhydrous methyl glyoxylate.29 The reaction rate of this condensation with glyoxylate proved to be strongly 
dependent on the steric bulk of the alkyl group. For example, the allyl precursor 13 (entiy 1) reacted within 2 h 
to give the desired product, while for the benzyl precursor 19 (entry 9) a longer reaction time was required (up 
to 40 h). Because polymerization of unreacted methyl glyoxylate was a major side reaction, freshly distilled 
methyl glyoxylate had to be added after 18 h if the reaction was not completed* In some cases, large amounts 
(ca. 20 equiv) of methyl glyoxylate were used, so that purification by flash chromatography of the intermediate 
hydroxy compound was necessary. Acétylation (acetic anhydride (5 equiv), DMAP (cat), pyridine, rt) led to the 
cyclization precursors 24-34 in good yields as shown in Table I.
The cyclization reactions were carried out with the Lewis acids titanium tetrachloride (2 equiv, -78 *C 
rt), tin tetrachloride (2 equiv, -78 *C rt), diethylaluminum chloride (2-4 equiv, -78 'C rt), and boron 
trifluoride etherate (2-6 equiv, 0 *C —» rt) and the protic acid formic acid (neat). The results are shown in Table L
Cyclization of the allyl precursor 24 (entry 1) led to the unexpected formation of the five-membered 
rings 35  with the trans-isomer as the main product. These products cannot arise from a ‘normal’ 5-« a -ty p e  
cyclization, because the chloromethyl substituent would then be at the 4-position. A possible explanation for the 
formation of 3 5  is detailed in eq 3. Presumably, cyclization initially gives rise to the formation of the secondary 
carbocation 50 (R = H), which is then trapped by the relatively nucleophilic N1 atom to give the aziridinium 
intermediate 51 (R «  H), Attack of chloride gives ring opening of the aziridirtium moiety, thus leading to the 
//my-azaproline derivative 3 5 . Similar types of ring contractions via aziridinium intermediates have been 
described in the literature.30
Alloc .  R^ —OAc
CO?Me 
24R  -  H 
25 R -  Me
A Hoc
50
+ ÇOaM»
Bn/ 3 < ÿ a
AilOC*"N
51
COgMe, r
Aiioc'
35 R
36 R
H
Me
(eq3)
It has been shown that in corresponding N-acyliminium cyclizations,18 the cationic intermediate is 
already formed at -78 *C and stabilized as a dioxycarbenium ion by the carbamate function (compare 53» eq 4). 
Quenching with saturated aqueous sodium bicarbonate at -78 *C then gives the corresponding hydroxy 
compound. In the case of these hydrazonium ions, such a sequence might block the rearrangement and directly 
give the precursor 54 for the piperazic acid 2. However, when the cyclization reaction of 24 was quenched with 
saturated aqueous sodium bicarbonate at -78 or at -30 "Cf only starting material was recovered. Apparently, 
formation of the W-acylhydrazonium ion is more difficult than of its iminium analog. Reaction only took place at 
-20 *C (according to TLC), but quenching after stirring for 30 min at this temperature afforded a mixture of 
starting material and the rearranged products 35. This probably means that as soon as the intermediate cationic 
six-membered ring 50 (R = H) is formed, stabilization via the aziridinium intermediate 51 (R = H) takes place 
so that stabilization via the dioxycarbenium ion 53 does not occur.
Bn'N
Alloc"NY OAC
CQiMe24
COzMe .
Alloc
52
Alloc
MeO^+^O N aH C03 CO9M6 1OH
Bn
Alloc*
<eq4)
53 54
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Table I. Synthesis of cyclic a-hydrazino add derivatives.
-nirv alkylation 
^  product (yield)
glyoxylate adduct 
(yield) acid cyclization products (yield)
Bnv
Alloc'
N
hlH
Bns
R
1 13 R =* H (89%)
2 14 R ss Me (78%)
3
Alloc" *spOAc
C02Ma
24R = H(9l% ) 
25 R » Me (98%)
Bn.
A.. ^Nv-OAcAlloc y
COaM«
4 15(66%)
5
B%
■
ah ^Nn^ OAcAlloc y
co2m*
26 (57%)
Bn
Alloc„NH
Bn N i
OAcAlloc"
C02M«
16 (73%) (E)/(Z) 3 3 :1  27(82% /
Bn»
Alloc
N 
„NH
Bn
A llo c 'V 0*0
COjMt
7 17(23%)
Bn.*
28 (83%)
Bn
Alloc’
NH
8 18(39%)
Bit
Allocò
v
NHr o
9 19(83%)'
AJIoc'N'Y 'OAC
COjMfl
29 (48%)
Ac0 Y n^ i ^ V
COjMa
30 (99%)
Bns
Alloc"NH 11 AIt X  £
10 20(58%)
11
AUoc",' v y—OAc
COaMa
31 (79%)
Alloc AUoc
COsMa v
SnCU
EfcAlCl
HCOOH
35 R 
36R
C02Ma 
H 05%) c/tr 1:5
Me (27%) cjtr 1:1,8 37 X = Cl (59%) c//r 1:8.8
38 X = OCHO (68%) trans
Ba>N - \
aikW x
COjMe
SnCU 39 X « Cl (58%) 
HCOOH 40 X * OCHO (66%)
BlkN - \  ƒ
c lAlloc \
SnCl*
COjW«
41 (56%) 5:1 mixture of isomers
Alloc"
COaMa
TiCU 42 (45%) 1.2:1 mixture of isomers
B
Alloc J
SnCI
co2m«
Cl
43 (65%) 1:1 mixture of isomers
COjM«
SnCU
Alloc
„NH
12 21(81%)
Alloc',V 0AC
COzMa
32 (82%)
44 (91%)
B>  
Alloc" ^
CO2MA
EljAlCl 45 (83%) 
CFjCOOH
Alloc"
COaWa
BFr OEt2 47 (30%)
Bn^ x N - -02CCF3
Alloc V
co2m*
46(70%)
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Table I (continued). Synthesis of cyclic a-hydrazino acid derivatives.
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alkylation 
product (yield)
glyoxylate adduct 
(yield) Mid cyclization products (yield)
Bn.
Alloc NH
13 22 (88%)
IM«3
SIM 03
Bns IMS,
CO, Mo
33 (74%)
Bn'N
A,loc'NH
14 23 (52%) (MW) 1:1.9
Bn
. N y 1
SIM ©3
S n a4
Albo- - ^
COjMa
34(79%) (£XZ) 1:1.2 SnCl
CHjCI
Bn'N * <
N / " S"
Altoo"
SIM«
COjMa
48(68%)
CH;CI
Bn' r i slMe,  B>  i.
Alloc "v Albc
CO2MO
49 (50%)
CC^Ma
4S (32%)
a) The (£)/(Z)-ratio could not be detennined from the1H NMR spectrum. b) Yield in one step from allylcaibizate (10).
The formation of the mw-five-membered ring was confirmed by reduction of the irani-cyclization 
product 35 with tri-n-butyltin hydride to give 56 (Chart 1), clearly showing the characteristic doublet of the 
methyl substituent in the NMR spectrum (0,98 ppm, d, /  -  7.1 Hz). The structure was further proven by an 
X-ray crystallographic analysis of the deprotected product 66 (Fig I). The formation of the cis-five-membered 
ring product 35 was concluded by comparison of the ^C  NMR data of the cis- and ¿ra/tr-isomers of 35.
An analogous mechanism in the case of the methallyl substituent 25 (entry 2) accounts for the formation 
of the mixture of the five- and six-membered rings 36 and 37, respectively. The formation of the five- 
membered rings 36 was proven by reduction of the mixture with tri-n-butyltin hydride to give 57 (Chart I). The 
relative configuration of trans-36 was secured by NOE difference *H NMR techniques. Irradiation of the 
methylene group adjacent to the chlorine atom showed an enhancement of H3, whereas irradiation of the methyl 
function did not. The more stable tertiary carbocation 50 (R = Me, eq 3) is less prone to be stabilized by the 
nitrogen atom and thus leads to a considerable amount of the six-membercd rings 37. The stereochemistry of the 
the cis- and products was assigned by subjecting trans-31 to NOE difference *H NMR techniques; 
irradiation of the methyl function showed an enhancement of the signal of one of the H6 protons and of the 
broad signal of both H4 protons. The fact that the signal of only one of the H6 protons was enhanced leads to 
the conclusion that the methyl group is in the axial position. In view of the proposed conformation of the 
intermediate hydrazonium species, the ester function is expected to be axially oriented. When formic acid was 
used for the cyclization (entry 3), only the trans six-membered ring 38 was found. The tertiary carbocation 50 
(R = Me) probably gives a faster reaction with formate as a result of the large excess of the nucleophile so that 
ring contraction is less likely to occur.
Cyclization of the prenyl precursor 26 (entries 4 and 5) afforded the expected five-membered rings 39 
and 40 with a íra/is-relationshíp between both substituents. Surprisingly, the crotyl precursor 2 7 (entry 6) also 
gave only a mixture of the ra/tf-five-membered ring products 41.
B>  
A H O C ^Y 0 ^
COjMe
26,27
COjMe
Alloc
CO^Me
Alloc
(eq 5)
55 39 R = R1 = Me, X * Cl
40 R » R‘ Me, X = OCHO 
41R -  Me, R’ = H, X » Cl
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The Jro/ts-relationship between the substituents of the products 3 9 ,4 0  and 41 is in accordance with the 
expected chair-like conformation 55 leading to the most favorable transition state (eq 5). The preference for the 
formation of a five-membered ring in the case of the crotyl precursor 27 is remarkable, because in similar 
cationic cyclizations six-membered rings are generally obtained. For example, comparable N-acyliminium ion 
precursors led to exclusive formation of six-membered rings.18b Reduction of the cyclization product 41 with 
tri'/i-butyl tin hydride afforded 58, thus confirming the formation of the five-membered ring. Hie trans- 
orientation was deduced from NOE difference NMR techniques. Irradiation of the methyl substituent of 41 
showed an enhancement of the signal of H3.
Chart I
Alloc
56 (65%)
C O ^e
57(51%)
Alloc
O zMe
58 (38%)
Additional evidence for the preference for the formation of five-membered rings was obtained upon 
cyclization of the allene precursor 2 8 (entry 7). Treatment of 2 8 with titanium tetrachloride afforded the five- 
membered rings 42 as a mixture of (£)/(Z> isomers that could not be separated by flash chromatography. A 
mechanism that accounts for the formation of 42 is shown in eq 6. Initially, cyclization takes place to afford the 
vinylic cation 59. This intermediate rearranges via a 1,2-H shift to the more stable tertiary allylic cation 60, 
which is trapped by chloride to afford 42.
A . O A c
Alloc Y
COaMe
28
Bn Hry .'t
Alloc”' N' \  +
COsMa
59
COjMe
60
Bn ____.
A l l O C ^
Cl
COjMa
42
(eq6)
The seven-membered rings 43 were obtained upon cyclization of the butenyl precursor 29 (entry 8). 
Cyclisation of the dibenzyl precursor 30 took place smoothly to give 44 in excellent yield (entry 9) although
cyclisation involving the benzyl function was not observed in any of the other reactions in table I. This is
» i
remarkable and might be partly explained by the difference in nucleophilicity with the other substituents, but also
by the strong preference for the formation of five-membered rings. Presumably, other systems are likely to
i
adopt a conformation in which the relatively large benzyl function is moved away from the glyoxylate moiety 
and thus will be less available for cyclization.
Another way to inhibit the ring contraction was observed upon cyclization of the allylsilane 31 (entry 
10). Treatment with diethylaluminum chloride initially led to the silicon stabilized carbocation 61 (eq 7) which 
gave a fast elimination to the exocyclic double bond. An indication that formation of six-membered rings in such 
systems is a relatively slow process, is seen in entry 11. Treatment of the allylsilane precursor 31 with 
trifluoroacetic acid afforded 46 as a single product, which is explained by protodesilylation of 31 to the 
methallyi precursor 25 (not isolated), followed by cyclization to the expected six-membered ring 46 (treatment 
of 31 with formic acid gave the corresponding formate 38 in 58% yield).
Alloc
COaMe
Alloc
C02Me
Bn^ Bns
45 61
AllocxNvpOAc
C02Me
31
Alloc
O fN. 11 
^pOAc
CÛ2Mo
25
Alloc
46
>0 2CCF3
(eq 7)
COjMa
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The fact that the cyclization product 45 appeared to be stable in formic acid indicates that the formation of 4 6 is 
not simply a result of addition of formic acid to the double bond after cyclization.
In an analogous way, the propargylsilane 32 (entry 12) was treated with boron trifluaride etherale to 
give the allene 47 in a rather poor yield.
A striking difference was observed between cyclization of the (£)~ and (Z)-vinylsilanes 33 and 34 
(entries 13 and 14). The chair-like transition state conformations of both starting materials are visualized in eqs 8 
and 9, respectively. The (£)-vinylsilane 33 will react via a chair-like conformation to the cyclic cationic 
intermediate 62 in which the trimethylsilyl group occupies the equatorial position. Because the p-C-Si bond is 
not coplanar with the vacant porbital, stabilization of the positive charge by the silicon atom and subsequent 
elimination is not likely to take place, thus leading to a ring contraction via the aziridinium intermediate 63. 
Attack of chloride affords the final product 48. The stereochemistry of the product was confirmed by subjecting 
48 to NOB difference *H NMR techniques, showing an enhancement of only H3 upon irradiation of the proton 
adjacent to the silicon atom.
CO2M6
AcO
COjMe
SIMO:
AÌÌOC
Sì Me:
Alloc
Bns
CHjCI
SiMa3
m cT
Ni
N
33 62 63 48
CO,
SIM03 (eq8)
0 Me
Cyclization of the (Z)-precursor 34 will occur via conformation 64 in which the trimethylsilyl group is 
axially oriented In this orientation, maximal a-rc hyperconjugative stabilization of the developing positive 
charge is possible, followed by fast elimination to the unsaturated six-membered ring 49, thereby excluding the 
formation of the aziridinium intermediate. Considering these mechanistic details, starting from the precursor 34, 
that was obtained as a 1:1.2 mixture of (£)- and (Z)-isomers* the corrected yields for 48 and 49 (entry 14) are 
70% and 90%, respectively. Comparing the yield of the five-membered ring product 48, with the yield of 48 
from the pure (E)-precursor 3 3 (entry 13), it is evident that the (Z)-isomer leads to exclusive formation of the 
six-membered ring 49.
COzMe
t o * )
34 64 49
OjMô ÇOjMô
✓N Alloc Ac0 SiMe3 AJIOC I ' JSiMOn
^  Bn
Alloc ¡z
These observations are in full accord with results published by Overman and co-workers,31 who reported the 
(Z> vinyl silane to be at least 7000 times more reactive than its (£)-analog in iminium ion cyclizations.
DEPROTECTION REACTIONS
The sequence of deprotection reactions developed for compound 35 is shown in eq 10. First, the Alloc 
group was converted into the acid-labile Boc group (eq 10) in a one-pot procedure via a so-called transprotection 
reaction {Pd(PPh3)4 (cat), BugSnH (1,1 equiv), B0C2O (2 equiv), CH2CI2, rt).20
£ h2ci Pd(PPh3)4, PH*ci ch2ci CH2CI
B% - \  BujSnH, Bn, '  Pd/CiHî HN^ f  2NHC1 h2+N-C
I \  1 y  ---------- 1 y  --------------- 1 /  to  IQ)
Alloc'* '^"\ Boc20 , boc"N^  HCÏ(cat), Boc"N" ^  60*C,2h HN"^
COjMe CH2CI2 COjMe McOH CCfeMô CCfcH
35 65(77%) 66(90%) 67(82%)
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Hydrogenation of 65 {10% Pd/C, H Q  (cat)} led to smooth removal of the benzyl group to give 6 6 , which was 
readily hydrolyzed to the HQ-salt 67 of the free a-hydrazine acid.
The structure of the five-rnembexed ring 66, including the r^ -re lad o n sh ip  between the substituents 
was secured by an X-ray crystallographic analysis of 66  as depicted in H g I  Beside the Wii-relationship, it 
clearly shows the difference between the almost planar carbamate nitrogen atom (N2) and the pyramidal amine 
nitrogen atom (Nl).
F igure  L Chem3D™ view of the crystal structure of 66  (hydrogens are not shown)*
Some of the cyclization products were subjected to these deprotection reactions of which the results air
summarized in Table IL
Table M. Deprotectton reactions.
entry
............I f ...........rrv “ " * " t  1 vn^ ftntrm riiT  1 1 n V f f  i f r f tn ' in fru m iitm n ir i f iY fr f
cyclization
product(s)
transpraifiction produces)
iMUflMl WiLtf iitriHHï
reduction product(s)
1
Bn
Alloc
"(l<fCl
CO2M©
41
Cl
42
Alloc
OOaMe
Bn
Alloc
44
“IjJ
¿4
COgMe
45
fH^CI
AJbc
$IM«3
COgMe
48
Bn
Boc
68 (54%)
80c
COaMe
69 (64%)
C02Me
70 (56%)
CHjCI
B n ^ - \
^  V s.M «,
Boc \
COjMa
73 (64%)
COaMe
71 (22%)
Cl
74 (65%)
Boc
HN
I
£H£I
SIMg
COgMa
75 (81%)
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The desired transprotected products could not be obtained in all cases. Transprotection of the five-membered 
rings proceeded in reasonable yields (entries 1 and 5), whereas the six-membered rings 44 and 45 also gave 
deprotection of the Alloc group to give the corresponding oxidized products 71 and 72 (entries 3 and 4). 
Apparently, the reaction with di-ierf-butyl dicarbonate is very sensitive to steric hindrance caused by the benzyl 
substituent and the methyl ester, which is more pronounced in the six-membered rings. The formation of the 
oxidized products might be explained by decarboxylation of the initially farmed tin carbamate 7 6 which will 
give a ring inversion to the thermodynamically more stable hydrazine 77 (eq 11).33 Once the ring inversion has 
taken place, oxidation occurs to give 7 2. Attempts to introduce smaller electrophiles like an acetyl function also 
failed.
Alloc' tt
45 B* Sn0P' 76 77 '  72 C° ’Me
(eq 11)
The seven-membered ring 42 (entry 3), however, afforded the transprotected product 69 in a reasonable 
yield. Probably, the methyl ester causes less steric strain in a larger, more flexible ring.
Analogous to the hydrazino acid derivative 65, debenzylation of 69 and 73 provided a good yield of the 
corresponding hydrazines 7 4 and 7 5 (entries 2 and 5).
CONCLUSIONS
It is evident that a large variety of cyclic a-hydrazino acid derivatives can be efficiently synthesized via 
this method Several conclusions can be drawn from the outcome of the cyclization reactions. The cyclizations 
show a strong preference few: the formation of five-membered rings, particularly illustrated by the crotyl and 
allene precursor, which both produced the corresponding five* instead of six-membered rings. Furthermore, if a 
six-membered ring is formed during the cyclization, stabilization of the cationic intermediate by the amine 
nitrogen atom may take place, leading to a five-membered ring via an aziridinium intermediate. This ring 
contraction can be inhibited by stabilization of the developing positive charge by a P-silicon substituent, 
followed by a fast elimination process. A remarkable difference in reactivity is observed between the benzyl 
group and the non-aromatic %-nucleophiles; cyclization of the benzyl group only takes place if no other 
nucleophile is present in the molecule* Deprotection is carried out by the transprotection method This method 
fails in most six-membered ring cases, probably due to steric hindrance.
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EXPERIMENTAL
*
All reactions were carried out under an inert atmosphere of dry nitrogen, unless otherwise described. 
Standard syringe techniques were applied for transfer of Lewis acids and dry solvents. Infrared (IR) spectra 
were obtained from CHCI3 solutions, unless indicated otherwise, using a Perkin-Elmer 1310 spectrophotometer 
and wavelenghts (v) are reported in cm’ Proton nuclear magnetic resonance (*H NMR) spectra were 
determined in CDCI3 (unless indicated otherwise) using a Bruker AC 200 (200 MHz), a Broker WM 250 (250 
MHz) or a Bruker AMX 300 (300 MHz) spectrometer. The latter three machines were also used for ^C  NMR 
(APT) spectra (50, 63 and 75 MHz respectively) in CDCI3 (unless indicated otherwise). Chemical shifts (5) are
8614 F. P. J. T. Rutjes et al.
given in ppm downfield from tetramethylsilane. Low and high resol utionmass spcctra were recorded by using a 
Varian MAT 711 or a VG Micromass ZAB-2HF instrument Elemental analyses were performed by Domis u. 
Kolbe Mikroanalytisches Laboratoriura, MUlheim a.d. Ruhr, Germany« /?ƒ values were obtained by using thin- 
layer chromatography (TLC) on silica gel-coated plastic sheets (Merck silica gel 60 F254) with die indicated 
solvent(mixture). Chromatographic purification refers to flash chromatography (fc)^  using the same solvent as 
for TLC and Merck silica gel 60 (230-400 mesh) or Janssen Chimica silica gel (Q.030-0.075 mm)* Melting and 
boiling points are uncorrected. CH2CI2 was distilled from P2O5 and stored over MS 4A under an atmosphere 
of dry nitrogen. T1CI4 and Snd4  were distilled and stored under a dry nitrogen atmosphere as a solution in 
CH2Q2* BF3*OEt2 was distilled and stored under a dry nitrogen atmosphere. Dry THF and Et2 0  were distilled 
from sodium benzophenone ketyl prior to use.
Allyl carbazate (10). To a solution of hydrazine hydrate (128 mL, 2.64 mmol) in EtOH (1.3 L) was added 
dropwise in 1.5 h allyl chloroformate (70.0 mL, 0.66 mmol) while the temperature inside the flask was kept 
around -20 #C. The mixture was allowed to warm to rt, stirred at ambient temperature for 1 h and after addition 
of K2CO3 (91,2 g, 0.66 mol), it was stirred for an additional hour, After filtration and concentration in vacuo, 
the residue was distilled to afford 10 (59.2 g, 0.51 mol, 11%) as a colorless oil, bp 82 *C (0,3 mra), R f 0.35 
(ethyl acetate/hexane 1:1). IR v 3460, 3350, 1710, 1625, 995, 935; *H NMR (200 MHz) 8 3.66 (br s, 2 H, 
NH2). 4.56 (d, J =  5.6 Hz, 2 H, OCH2), 5.15-5.31 (m, 2 H, -CH2), 5.77-5.97 (m, 1 H, =CH), 6.61 (br s, 1
H, NH).
l-B enzyl-2 -hydrazinecarboxyIic acid ally! ester (12), To a solution of allyl carbazate (10), (10.0 gT 
86.2 mmol) in toluene (170 mL) was added benzaldehyde (9.1 mL, 90.5 mmol) and the mixture was stirred at rt 
for 18 h. Filtration and recrystallization (ethyl acetate/hexane/methanol 5:10:1) afforded the hydrazone 11 (16.5 
g, 80.9 mmol, 94%) as white crystals, mp 147-148 *C. IR V 3400, 3340, 1730, 690; %  NMR (250 MHz) 8 
4.64 (d, J ~  5.4 Hz, 2 H, OCH2), 5.24-5.41 (m, 2 H, -CH2), 5.90-6.06 (m, 1 H, =CH), 7.24 (s, 1 H, ArH),
7.34 (m, 2 H, ArH), 7.68 (m, 2 H, ArH). 7.86 (s, 1 H, NH), 8.01 (s, 1 H, N=CH). A solution of pTSA (23.6 
g, 124 mmol) in THF (125 mL) was added dropwise in 2.5 h to a solution of the hydrazone 11 (25.3 g, 124 
mmol) and NaBI^CN (9.18 g, 124 mmol) in THF (300 mL) and the mixture was stirred for one additional 
hour at n. The resulting mixture was diluted with ethyl acetate (600 mL) and extracted subsequently with aq satd 
NaCl (600 mL), aq satd NaHCC>3 (600 mL) and aq satd Nad (600 mL). The organic layer was dried (MgSO^), 
filtered, concentrated in vacuo, taken up in 1 N NaOH (250 mL), stirred at ambient temperature for 1.5 h, 
neutralized with 2 M HC1 and extracted with CH2CI2 (3 x 100 mL). The combined organic layers were dried 
(MgSC>4), filtered and concentrated in vacuo to afford 12 (25.3 g, 123 mmol, 99%) as a colorless oil, RfOAS 
(ethyl acetatc/hexane 4:1). IR v 3440, 3340, 1710, 990, 930, 690; %  NMR (200 MHz) 8 4.00 (s, 2 H, 
Ctf2Ph), 4.25 (br s, 1 H, NH), 4.61 (d, /  = 5.5 Hz, 2 H, OCH2), 5.20-5.35 (m, 2 H, -CH2), 5.82-6.01 (in, 
1 H, =CH), 6.44 (br s, 1 H, NH), 7.26-7.36 (m, 5 H, ArH).
General procedure A for the alkylation reactions. To a solution of 12 in 2-butanone, EtOH or acetone 
were added the alkylating agent (1.1-2 equiv), K2CO3 (1.1-2 equiv) and a catalytic amount of UI. After heating 
at reflux temperature for 18 h, the mixture was concentrated in vacuo, taken up in H2O and extracted with 
CH2CI2 (3 x). The combined organic layers were dried (MgSC^, filtered, concentrated in vacuo and purified 
by fc to afford the pure alkylated hydrazine.
l-B en zyl-l-(2-propenyl)-2-h ydrazin ecarboxylic acid allyl ester (13). Following the general 
procedure A, 12 (3.00 g, 14.6 mmol) was alkylated by using allyl bromide (3.52 g, 29.1 mmol) and K2CO3 
(2.00 g, 14.6 mmol) in EtOH (100 mL). Work-up and fc (ethyl acetate/hexane 1:4) afforded 13 (3.20 g, 13.0 
mmol, 89%) as a white solid, mp 34-36.5 *C, R f 0.30. IR v 3430, 3330, 1720, 690; *H NMR (200 MHz) 8 
3.45 (br s, 2 H, NCH2), 3.99 (br s. 2 H, C//2Ph), 4.52 (d ,/=  5.4 Hz, 2 H, OCH2), 5.15-5.28 (m. 4 H, 2  x 
=CH2) , 5.76-6.03 (ffl.3 H .2 x =CHand NH),7.30*7.35 (m ,5 H, ArH).
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l-Benzyl-l-(2-methyI-2-prqpenyl)-2-hydrazinecarboxylic acid allyl ester (14). According to the 
general procedure A, 12 (10.0 g, 48.5 mmol) was alkylated by using 3~chloro-2-methyl-2-propene (5.28 mL,
53.4 mmol) and K2CO3 (7.38 g, 53.4 mmol) in EtOH (250 mL). Work-up and fc (ethyl acetate/hexane 1:4) 
afforded 14 (9.81 g, 37.7 mmol, 78%) as a light yellow oil. R f  0.30.1R v 3440, 3340, 1720,695; !H NMR 
(200 MHz) 8  1.83 (s, 3 H, CH3), 3.41 (br s, 2 H, NOfrj), 4.02 (br s, 2 H, Cff2Ph), 4.53 (d, J  = 5.2 Hz, 2 
H, OCH2), 4.90 (d,7= 6 .6  Hz, 2  H, C=CH2), 5.16-5.28 (m, 2 H, CH=Ctf2), 5.75-5.95 (m, 2 H, =CH and 
NH), 7.26-7.38 (m, 5 H, ArH).
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l-BenzyI-l-(3-methyl-2-buteiiyl)-2-hydrazinecarboxylic acid allyl ester (15). According to the 
general procedure A, 12 (7.04 g, 34.2 mmol) was alkylated by using 4-bromo-2-methyl-2-butene (5.60 g, 37.6 
mmol) and K2 CO3 (5.20 g, 37.6 mmol) in EtOH (300 mL). Work-up and fc (ethyl acetate/hexane 1:4) afforded
15 (2,89 g, 10.5 mmol, 66% (after correction)) as a light yellow oil* R f  0.40. IR v 3440,3340,1725,690; ^H 
NMR (200 MHz) 8  1.63 (s, 3 H, CH3), 1.74 (s, 3 H, CH3), 3.45 (br s, 2 H, NCH2), 3.97 (br s, 2 H, 
C//2Ph), 4.52 (d, J  =  5.3 Hz, 2 Hf OCH2), 5.14-5.36 (m, 3 H, =CH2 and NCH2CH) t 5.75-5.95 (m, 2 H, 
=CH and NH), 7.23-7.34 (m, 5 H, ArH).
l-BenzyM«(2-butenyI)-2-hydrazinecarboxylic acid allyl ester (16). According to the general 
procedure A, 12 (10.0 g, 48.5 mmol) was alkylated by using 4-bromo-2-butene ((£)/(Z) 3.3:1, 5.28 mL, 53.4 
mmol) and K2CO3 (7.38 g, 53.4 mmol) in EtOH (250 mL). Work-up and fc (ethyl acetate/hexane 1:4) afforded
16 (9.18 g, 35.3 mmol, 73%) as a light yellow oil, (fi)/(Z) 3.3:1, Rf  0.35. IR v 3440, 3340, 1720, 690; JH 
NMR (200 MHz) 8  1.64 (d, J - 6.4 Hz, 3 H, CH3 (20), 1.70 (d, 7 = 5.0 Hz, 3 H, CH3(£)), 3.38 (br s. 2 H, 
NCH2), 3.95 (br s, 2 H, CW2Ph), 4.52 (d, /=  5.3 Hz, 2 H, O O ty , 5.14-5.26 (m, 2 H, =CH2), 5.45-5.92 
(m, 4 H, =CH, NH and CH=CH), 7.26-7.32 (m, 5 H, ArH).
l-BenzyI-l-(ethenylidenemethyl)«2-hydrazinecarboxylic acid allyl ester (17). According to the 
general procedure A, 12 (2.32 g, 11.3 mmol) was alkylated by using 4-iodo-l-(trimethylsilyl)-2-butyne^ 
(4.09 g, 12.4 mmol) and K2CO3 (1.71 g, 12.4 mmol) in EtOH (100 mL). Work-up and fc (ethyl acetate/hexane 
1:5) afforded 17 (670 mg, 2.60 mmol, 23%) as an orange oil, Rf  0.40. IR v 3440, 3340,1950,1725,690; %  
NMR (200 MHz) 8 3.64 (br s, 2 H, NCH2), 4.00 (br s, 2 H, CW2Ph), 4.54 (d, J  - 5.5 Hz, 2 H, OCH2),
4.76 (dt, J  = 6.5, 2.3 Hz, 2 H, C=CH2), 5.16-5.28 (m, 3 H, CH=Cff2 and C tf-CCH^, 5.77-5.96 (m, 2
H, =CH and NH), 7.27-7.36 (m, 5 H, ArH).
l-BenzyK-l-(3-butenyl)»2«hydrazinecarboxylic acid allyl ester (18). According to the general 
procedure A, 12 (2.91 g, 14.1 mmol) was alkylated by using 4-bromo-l-butene (2.10 g, 15.5 mmol) and 
K2CO3 (2.15 g, 15.5 mmol) in EtOH (150 mL). Work-up and fc (ethyl acetate/hexanc 1:4) afforded 18 (384 
mg, 1.50 mmol, 39% (after correction)) as white crystals, mp 50-51 *C, R f  0.45. IR V 3440,3340,1740, 690; 
!H NMR (200 MHz) 8  2.26-2.34 (m, 2 H, NCH2C//2), 2.70-2.95 (br s, 2 H, NCH2 ), 3.80-4.15 (m, 2 H, 
CH2Ph), 4.55 (d, /  = 5.4 Hz, 2 H, OCH2), 4.98-5.21 (m, 4 H, 2  x =CH2), 5.55-5.95 (m, 3 H, 2  x =CH and 
NH), 7.26-7.35 (m, 5 H, ArH).
I,l-Dibenzyl-2 -hydrazinecarboxylic acid allyl ester (19). According to the general procedure A, 10 
(15.0 g, 130 mmol) was alkylated by using benzyl chloride (29,7 mL, 260 mmol) and K2C0 3  (36 g, 260 
mmol) in EtOH (300 mL). Work-up and fc (ethyl acetate/hexane 1:4) afforded 19 (31,9 g, 110 mmol, 83%) as a 
white solid, mp 52-54 ’C, RfOAS. IR V 3440, 3340, 1725, 690; %  NMR (200 MHz) 8 3.96 (br s, 4 H, 2 x 
Ctf2Ph), 4.49 (d, J  = 5.5 Hz, 2 H, OCH2), 5.12-5.19 (m, 2 H, =CH2), 5.73-5.92 (m, 2 H, =CH and NH),
7.24-7.32 (m, 10 H, ArH); Anal. Calcd. for C]gH2()N2Q2: 72.95; H, 6.80; N, 9.45. Found: C, 72.90; H, 
6.75; N, 9.54.
l-BenzyM-{2-[(trimethylsilyl)methyl]-2-propenyl}-2-hydrazinecarboxylic acid allyl ester 
(20), According to the general procedure A, 12 (3.42 g, 16.6 mmol) was alkylated by using 2-(chlorotnethyI)- 
3-(trimethylsilyl)-l-propene (2.97 g, 18.3 mmol) and K2CO3 (2.52 g, 18.3 mmol) in 2-butanone (175 mL).
8616 F. P. J. T. Rutjes et al.
Work-up and fc (ethyl acetate/hexane 1:4) afforded 20 (3.20 g, 9.60 mmol, 58%) as a colorless oil, R f  0.55. IR 
v 3440,3340,1720,1240,850,690; JH NMR (200 MHz) 8  -0.04 (s, 9 H, (CH3)3Si), 1.69 (s, 2 H, CH2Si),
3.35 (br s, 2 H, NCH2 ) , 4 0 3  <br S-2H - C//2Ph), 4.53 (d, / *  5.2 Hz. 2 H, OCHj), 4.68 (s, 1 H, OCffH ), 
4.85 (s, 1 H, C=CHH), 5.16-5.28 (m, 2 H, CH»C«2). 5.75-5.90 (m, 2 H, =CH and NH), 7.24-7.35 (m, 5
H, ArH).
1-Benzyl-l-[4-(trimethyIsilyl)-2-butenyl]-2-hydrazinecarboxylic acid allyl ester (21), 
According to the general procedure A, 12 (1.40 g, 6.80 mmol) was alkylated by using 4-iodo-l-(trimethylsilyl)~
2-butyne^ (1.88 g, 7.50 mmol) and KjCO^ (1,03 g, 7.50 mmol) in acetone (50 mL) by stirring atrt for 18 h. 
Work-up and fc (ethyl acetate/hexane 1:6) afforded 21 (1.82 g, 5.50 mmol, 81%) as a colorless oil, R f  035. IR 
v 3440, 3340, 2190,1730, 1240, 850, 690; *H NMR (200 MHz) 8 0.16 (s, 9 H, (CH3)3Si), 1.56 (t, 7- 2.4 
Hz, 2 H, CH2Si), 3.60 (t, 7=2.3 Hz, 2 H, NCH2), 3.90 (s, 2 H, C//2ph). 4.54 (dt, J  = 5.5, 1.3 Hz, 2 H, 
OCH2), 5.15-5.29 (m, 2 H, =CH2), 5.77 (m, 2 H, =CH and NH), 7.26-7.41 (m, 5 H, ArH).
l-Benzyl-l»[(E)«3«(trimethyIsilyI)-2'’propenyl)»2-fiydrazinecarbQxylic acid allyl ester (22), 
According to the general procedure A, 12 (6.23 g, 30.2 mmol) was alkylated by using (£)-3-bromo-l- 
(trimethylsilyl)-l-propene (4.09 g, 21.2 mmol) and K2CO3 (4,18 g, 30.2 mmol) in 2-butanone (250 mL). 
Work-up and fc (ethyl acetatevfoexane 1:4) afforded 22 (5.93 g, 18,6 mmol, 88%) as a colorless oil, fly 0.50, IR 
V 3440, 3340, 1740, 1245, 835, 690; NMR (200 MHz) 8 0.06 (s, 9 H, (CH3)3Si), 3.48 (br s, 2 H, 
NCH^, 3.98 (br s, 2 H, C//2Ph), 4.52 (d, /  - 5.0 Hz, 2 H, OCH2), 5.15-5.27 (m, 2 H, -CH2), 5.70-5.91 
(m, 2 H, C//-CH2, NH and CHSi), 6.12 (dt, J  =  18.6,5.8 Hz, 1 H, CH2CH),  7.27-7.35 (m, 5 H, ArH).
l~Benzyl»l-[(Z)-3-(trimethylsiIyl)*2*propenyl)*2-hydrazinecarboxyUc add allyl ester (23). 
According to the general nrocedure A, 12 (3,71 g, 18,0 mmol) was alkylated by using 3-bromo-l- 
(trimethylsilyl)-l-propen^o (2.31 g, 12.0 mmol, (E)/(Z) 1:2,5) and K2CC>3 (2.65 g, 19.2 mmol) in 2- 
butanone (130 mL). Work-up and fc (ethyl acetate/hexane 1:4) afforded 23 (1.97 g, 6.19 mmol, 52%) as a 
colorless oil, (£)/(Z) 1:1.9, R f  0.50. IR V 3440, 3340,1740,1245, 835, 690; JH NMR (250 MHz) 8 0.07 (s, 
9 H, (CH3)3Si), 3.55 (br s, 2 H, NCH2). 4.00 (br s, 2 H, CH2Ph), 4.52 (d, J  *  4.8 Hz, 2  H, O O ty . 5.18- 
5.28 (m, 2 H, =CH2), 5.75-5.88 (m, 2 H, Ctf=CH2, NH and CHSi), 6.41 (dt, J  * 14.3, 7.2 Hz, 1 H, 
CH2CW), 7.27-7.35 (m, 5 H, ArH).
General procedure B for the reactions with methyl glyoxylate, To a solution of the hydrazine in 
toluene was added an excess of freshly distilled methyl glyoxylate at After complete reaction (according to 
TLC), the solution was concentrated in vacuo. The residue was taken up in pyridine and treated with an excess 
of acetic anhydride and a catalytic amount of DMAP. After stirring at it for 18 h, the dark brown solution was 
concentrated in vacuo and purified by fc to afford the pure product.
a-Acetoxy-l-(allyloxycarbonyl)-2-benzyl-2*(2-propenyl)hydrazineacetic acid methyl ester 
(24). Following the general procedure B, a solution of 13 (3.20 g, 13.0 mmol) in toluene (100 mL) was 
reacted with methyl glyoxylate (2.29 g, 26.0 mmol) for 4 h and acetylated with Ac20 (6,15 mL, 65.0 mmol) in 
pyridine (100 mL). Concentration in vacuo and fc (ethyl acetate/hexane 1:5) afforded 24 (4.45 g, 11.8 mmol, 
91%) as a colorless oil, R f  0.45. IR V 1760, 1740, 1710, 1360, 690; JH NMR (200 MHz) 8 (some signals 
appear as rotamers) 1.97, 2.00 (s, 3 H, C(0 )CH3), 3.50-3.81 (m, 2 H, NCH2), 3.66, 3.73 (s, 3 H, 
CO2CH3), 4.17-4.25 (m, 2 H, C//2Ph), 4.68 (br s, 2 H, OCH2), 4.98-5.34 (m, 4 H, 2 x =CH2), 5.54-6.03 
(m, 2 H, 2 x =CH), 6.55, 6.57 (s, 1 H, NCH), 7.21-7,33 (m, 5 H, ArH).
<x-Acetoxy-l-(aHyloxycarbonyl)-2*benzyN2-(2-methyl-2-propenyl)hydrazlneacetic acid 
methyl ester (25), Following the general procedure B, a solution of 14 (4.00 g, 15.4 mmol) in toluene (150 
mL) was reacted with methyl glyoxylate (9.5 g, 0.11 mol) for 18 h and acetylated with At^O (7.3 mL, 0,08 
mol) in pyridine (150 mL). Concentration in vacuo and fc (ethyl aceiatc/hexane 1:5) afforded 25 (5.88 g, 15.1 
mmol, 98%) as a colorless oil, R f 0.30. IR V 1760, 1740, 1720, 690; *H NMR (250 MHz) 8 1.80 (s, 3 H,
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CH3), 1.91 (s, 3 H, C(0)CH3), 3.41-3.74 (m, 2 H, N O ty , 3.64 (s, 3 H, C02CH3), 3.95-4.25 (m, 2  H, 
CH2m , 4.60 (br s, 2  H, OCH2), 4.80-4.90 (m, 2  H, C*CH2), 5.10-5.45 (m, 2 H, CH=Ctf2). 5.75-6.05
(m, 1 H, =CH), 6.44 (br s, 1 H, NCH), 7.20-7.33 (m, 5 H, ArH).
t
a-Acetoxy-l-(allyIoxycarbonyl)-2-benzyI-2-(3-methyl-2-butenyl)hydrazineacetk add methyl 
ester (26). According to the general procedure B, a solution of 15 (800 mg, 2.90 mmol) in toluene (30 mL) 
was reacted with methyl glyoxylate (2.6 g, 29 mmol) fcr 18 h and acetylated with AC2 O (2.76 mL, 29 mmol) in 
pyridine (50 mL). Concentration in vacuo and fc (ethyl acetate/hexane 1:4) afforded 26 (670 mg, 1.70 mmol, 
57%) as a colorless oil, R f  0.40. IR v 1760, 1735, 1715, 690; NMR (250 MHz) 8  1.53-1.73 (m, 6 H, 
(CH3)2C), 1.98 (s, 3 H, C(0)CH3), 3.40-3.75 (m, 5 H, NCH2  and C0 2 CH3), 4.10-4.25 (m, 2 H, CW2Ph), 
4.60-4.80 (m, 2 H, OCH2), 5.15-5.45 (m, 3 H, CH2 and C-Cff), 5.75-6.05 (m, 1 H, CH2=CW), 6.51 (s, 1
H, NCH), 7.19-7.34 (m, 5 H, ArH).
a-Acetoxy-l">(al)yfoxycarbonyl)-2-benzyl«2-(2«butenyl)hydraztneacetic add methyl ester
(27). Following the general procedure B, a solution of 16 (3.00 g, 11.5 mmol) in toluene (120 mL) was 
reacted with methyl glyoxylate (7.1 g, 80 mmol) for 4 h and acetylated with Ac20 (7.5 mL, 80 mmol) in 
pyridine (125 mL). Concentration in vacuo and fc (ethyl acetate/hexane 1:4) afforded 27 (3.70 g, 9.5 mmol, 
82%) as a colorless oil, R f  0.30. IR v 1760, 1710, 690; *H NMR (300 MHz) 8 (some signals appear as 
rotamers) 1.58, 1.64 (m, 3 H, CH3), 2.01, 2.05 (s, 3 H, C(0)CH3), 3.50-3/73 (m, 2 H, NCH2), 3.66, 3.74 
(s, 3 H> C02CH3), 4.10-4.25 (m, 2 H, C/f2Ph), 4.60-4.75 (m, 2 H, OCH2), 5.23-5.35 (m, 2 H, -CH^, 
5.48-5.57 (m, 2 H, CH*CH), 5.80-6.10 (m, 1 H, CH2*C/Z), 6.54 (s, 1 H, NCH), 7.22-7.33 (m, 5 H, ArH).
a-Acetoxy»l*(allyloxycarbonyl)«2*benzyl-2-(ethenylidenemethyI)hydrazineacetic add methyl 
ester (28). Following the general procedure B, a solution of 17 (530 mg, 2.10 mmol) in toluene (25 mL) was 
reacted with methyl glyoxylate (720 mg, 8.2 mmol) for 4 h and acetylated with Ac20  (0.97 mL, 10.3 mmol) in 
pyridine (25 mL). Concentration in vacuo and fc (ethyl acetate/hexane 1:6) afforded 28 (660 mg, 1.70 mmol, 
83%) as a yellow oil, R f  0.40. *H NMR 8 (some signals appear as rotamers) 2.01 (s, 3 H, C(0)GH3), 3.48- 
3.91 (m, 2 H, NCH2), 3.68, 3.74 (s, 3 H, C02CH3), 4.05-4.40 (m, 2 H, C//2Ph), 4.55-4.95 (m, 4 H, 
OCH2 and C=CH2), 5.10-5,50 (m, 3 H, CH*Ctf2 and C*C//), 5.75-6.10 (m, 1 H, CH2=C/ƒ), 6.57, 6.60 
(s, 1 H, NCH), 7.26-7.34 (mf 5 H, ArH).
cx-Acetoxy-l-(allyloxycarbonyl)-2-benzyl-2-(3-butenyl)hydrazineacetic acid methyl ester 
(29). Following the general procedure B, a solution of 18 (384 mg, 1.48 mmol) in toluene (15 mL) was 
reacted with methyl glyoxylate (650 mgt 7.4 mmol) for 5 h and acetylated with Ac2Ö (0.70 mL, 7.38 mmol) in 
pyridine (15 mL). Concentration in vacuo and fc (ethyl acetate/hexane 1:4) afforded 29 (279 mg, 0.72 mmol, 
48%) as a colorless oil, R f  0.45. IR v 1765,1740, 1715, 690; *H NMR (200 MHz) 8 (some signals appear as 
rotamers) 2.03, 2.06 (s, 3 H, C(0)CH3), 2.25-2.35 (m, 2 H, NCH2Ctf2), 2.75-3.35 (m, 2 H, NCH2), 3.70, 
3.73 (s, 3 H. C02CH3), 4.10-4.30 (m, 2 H, Ctf2Ph), 4.68 (br s, 2 H, OCH2), 4.88-5.03 (m, 2 H, =CH2), 
5.20-5.45 (m, 2 H, =CH2), 5.50-6.00 (m, 2 H, 2 x =CH), 6.54 (s, 1 H, NCH), 7.22-7.40 (m, 5 H, ArH).
a-Ac6toxy-l-(allyloxycarbonyI)~2,2-dibenzylhydrazineacetic add methyl ester (30). According 
to the general procedure B, a solution of 19 (10.0 g, 33.8 mmol) in toluene (200 mL) was reacted with methyl 
glyoxylate (5.95 g, 68 mmol) for 40 h and acetylated with Ac20 (16.0 mL, 169 mmol) in pyridine (200 mL). 
Concentration in vacuo and fc (ethyl acetate/hexane 1:4) afforded 30 (14.3 g, 33.6 mmol, 99%) as a colorless 
oil, R f  0.30. IR V 1760, 1735, 1715, 1220, 690; !H NMR (200 MHz) 8 1.77 (br s, 3 H, C(0)CH3), 3.57 (s, 
3 H, C02CH3), 4.10-4.41 (m, 4H ,2x  CW2Ph), 4.69 (br s, 2 H, OCH2), 5.15-5.40 (m, 2 H, =CH2), 5.60- 
6.10 (m, 1 H, -CH), 6.42 (s, 1 H, NCH), 7.21-7.37 (m, 10 H, ArH).
a-A ce toxy- l- (a lly loxycarbony I)- 2 *benzyl-2 *{2 -[(tr im ethy ls ily l) ine thy l]- 2 * 
propenyl}hydrazineacetic acid methyl ester (31)* Following the general procedure B, a solution of 20 
(L00 g, 3.01 mmol) in toluene (30 mL) was reacted with methyl glyoxylate (2.65 g, 30.1 mmol) for 18 h (2 x)
8618 F. P. J. T. Rirrres et al.
and acetylated with A ^O  (1.42 mL, 15.1 mmol) in pyridine (30 mL). Concentration in vacuo and fc (ethyl 
acetatq/hcxane 1:4) affixded 31 (1.10 g, 2.38 mmol, 79%) as a colorless oil,Rf 0.50. IR v 1760, 1735,1715, 
1240, 850, 690; * H NMR (200 MHz) 8 (some signals appear as rotamers) 4). 10, -0.09 (s, 9 H, (CH3)3Si),
1.43.1.63 (s, 2 H, CH2Si), 1.91 (s. 3 H, C(0)CH3), 3.25-3.70 (m, 2 H, NCH2), 3.66 (s, 3 H, C02CH3), 
3.85-4.35 (m, 2 H, CH2Ph), 4.50-4.75 (m, 3 H, OCH2 and C*CHH), 4.88 (s. 1H. O C H H), 5.15-5.50 (m, 
2 H, CH=CW2). 5.75-6.10 (m, 1 H, =CH), 6.42 (s, 1 H, NCH), 7.22-7.34 (m, 5 H. ArH).
a-Acetoxy-l-(&llyloxycarbonyl)-2-benzyl-2-[4-(triinethylsilyl)-2-biitynyl]hydrazineacetic
acid methyl ester (32). According to the general procedure B, a solution of 21 (150 mg, 0.45 mmol) in 
toluene (5 mL) was reacted with methyl glyoxylate (9.5 g, 0.11 mol) for 4 h at 80 *C and acetylated with AcgO 
(220 |xL, 2.27 mmol) in pyridine (5 mL). Concentration In vacuo and fc (ethyl acetate/hexane 1:6) afforded 32 
(170 mg, 0.37 mmol, 82%) as a light yellow oil, Rf0.35. IR v 2210,1765,1735,1715,1245, 845,690; %  
NMR 8 (some signals appear as rotamers) 0.08,0.09 (s, 9 H, (CH3)3Si), 1.40-1.55 (m, 2 H, CH2Si), 1.75- 
ZOO (m, 3 H, C(0 )CH3), 3.55-3.95 (m> 5 H, NCH2  *nd CC^Oty, 4.24 (br s, 2  H, Cff2Ph), I * 6 2 H* 
OCH2), 5.15-5.36 (m, 2 H, =CH2), 5.82-5.96 (m, 1 H, *CH), 6.50 (s, 1 H, NCH)* 7.26-7.37 (m, 5 H,
ArH).
a - A c e to x y - l- (a l Iy Io x y c a rb o n y l)- 2  -benjcyI-2 * [ ( i? )*3- (tr im e thy Is lIy I)-2-  
propenyl)hydrazineacetic acid methyl ester (33). Following the general procedure B, a solution of 22 
(5.93 g, 18.6 mmol) in toluene (200 mL) was reacted with methyl glyoxylate (13.1 g, 150 mmol) for 42 h and 
acetylated with Ac20  (17.6 mL, 0.19 mol) in pyridine (200 mL). Concentration in vacuo and fc (ethyl 
acetate/hexane 1:3) afforded 33 (6.20 g, 13.8 mmol, 74%) as a light yellow oil, /?ƒ 0.50. IR v 1765, 1700, 
1240, 840, 690; ^H NMR (200 MHz) 8 (some signals appear as rotamers) -0.06, 0.00 (s, 9 H, (CH3)3Si), 
2.00, 2.05 (s, 3 H, C(0)CH3), 3.68 (br s, 2 H, NCH2), 3.75 (s, 3 H, C02CH3), 4.05-4.25 (m, 2 H, 
Ctf2Ph), 4.55-4.80 (m, 2 H, OCH2), 5.15-5.50 (m, 2 H, =CH2), 5.68-5.77 (m, 2 H, CH-CH), 5.80-6.15 
(m, 1 H, CH2=C//), 6.50, 6.60 (s, 1 H, NCH), 7.24-7.32 (m, 5 H, ArH)*
a- A ce to x y - l- (a l ly lo x y ca rb o ny l)- 2 - b e n zy l- 2 - [ (Z )- 3 - ( tr im e th y ls i ly l)- 2 -  
propeny])hydrazineacetic acid methyl ester (34). Following the general procedure B, a solution of 23 
(1.95 g, 6.13 mmol) in toluene (60 mL) was reacted with methyl glyoxylate (2.70 g, 30.7 mmol) for 42 h and 
acetylated with Ac20  (5.8 mL, 61 mmol) in pyridine (60 mL). Concentration in vacuo and fc (ethyl 
acetate/hexane 1:4) afforded 34 (2.17 g, 4.84 mmol, 79%) as a light yellow oil, (£)/(Z) 1:1.2, R f  0.50. IR v 
1760,1740,1720, 1240,835,690; *H NMR (250 MHz) 5 0.05 (s, 9 H, (CH3)3Si), 1.94 (s, 3 H, C(0)CH3), 
3.64 (br s, 2 H, NCH2), 3.70 (s, 3 H, C02CH3), 4.05-4.22 (m, 2 H, Ctf2Ph), 4.65-4.75 (m, 2 H, OCH2), 
5.15-5.35 (m, 2  H, =CH2>, 5.40-6.00 (m, 2 H, CHSi and =*CH), 6.42 (dt. ƒ  * 14.3, 7.2 Hz, 1 H, CH2Ctf),
6.63 (s, 1 H, NCH), 7.22-7.32 (m, 5 H, ArH).
General procedure C for the cyclization reactions with Lewis acids. To a 0.1 M solution of the 
hydrazide in CH2C12 was added TiCl^ SnCl4  (2 equiv of a solution in CH2C12) or Et2AlCl (2 equiv of a 1.0 
M solution in toluene) at -78 *C by a syringe. The mixture was stirred at -78 *C for 15 min and for 5-18 h at it, 
The reaction mixture was poured into cold aq s&td NaHC03 and the resulting suspension was filtered over 
Celite and extracted with CH2C12  (3 x). The combined organic layers were dried (MgSC^), filtered and 
concentrated in vacuo. Purification of the residue by fc afforded the pure cyclization product(s).
re/*(3S,5S)-2-(AIlyloxycarbonyI)-l-benzyl-5-(chloromethyl)-3-pyrazoHdinecarboxyIic acid 
methyl ester (iranj-35). According to the general procedure C, a solution of 24 (500 mg, 1.33 mmol) in 
CH2Q 2 (13 mL) was cyclized by using SnCl4 (1.33 mL of a 2.0 M solution, 2.66 mmol). Work-up and fc 
(ethyl acetate/hexane 1:4) afforded 35 (352 mg, 1.00 mmol, 75%) as a colorless oil, c/tr 1:5, fly 0.25. trans- 
35: IR V 1740, 1680,1375,690; JH NMR 8  2.46-2.72 (m, 2 H, 2 x H4). 3.11 (dd, J  * 8 .8 , 10.6 Hz, 1 H, 
CtfHCl), 3.31-3.44 (m, 2 H, CHtfCl and H5), 3.80 (d ,/=  12.6 Hz, 1 H. CtfHPh), 3.81 (s, 3 H, C02CH3),
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4.24 (d, ƒ  = 12.6 Hz, 1 Hf CHtfPh), 4.50-4.60 (m, 2 H, OCHj), 4.67 (t, J - 8.8 Hz, 1 H, H3), 5.17-5.35 
(m, 2 H, -CH2), 5.79-5.97 (m, 1 H, =CH), 7.27-7.47 (m, 5 H, ArH); I3C NMR (50 MHz) 8 31.9 (C4),
45.0 (CH2C1), 52.6 (C0 2CH3), 59.4 (C3), 62.1 (CH2Ph)> 6 4 1  (C5)» 66 4  (O O ty , 117.5 (=CH2>, 127.7, 
128.4, 129.4 (ArH), 132.5 (=CH), 137.0 (ArC), 172.6 (C(G)); MS (El, 70 eV) mlz (relative intensity) 352
13C NMR (50 MHz) 8  31.3 (C4), 44.5 (CH2a ), 52.4 (CO2CH3), 58.6 (C3), 60.6 (CH2Ph), 64.0 (C5), 66.4 
(OCH2), 117.7 (=CH2). 127.8,128.4,129.4 (ArH), 132.4 (=CH), 136.2 (AiC), 171.6 (C(0)).
Cyclization of 25 with Et2AKCL Following the general procedure C, a solution of 25 (982 mg, 2.52 
mmol) in CH2Q 2 (25 mL) was treated with Et2AlCl (7,55 mL of a 1.0 M solution in toluene, 7.55 mmol). 
Work-up and fc (ethyl acetate/hexane 1:5) afforded re/-(35,55)-2»(aIIyloxycarbQnyI)-l-benzyl-5- 
chIoro-5-methylhexahydro-3-pyridazinecarboxylic acid methyl ester (fr««s-37) (488 mg, 1.33 
mmol, 53%) as a colorless oil, rW*(35»55)*2»(a]ly]oxycarbonyl)*l-benzyl«5-(ch]oromethy])^5- 
methyI-3-pyrazolidinecarboxyHc acid methyl ester (traits*36) (178 mg, 0.49 mmol, 19%) as an 
inseparable mixture with c/s*37 (59 mg, 0.16 mmol, 6%) and cis*36 (76 mg, 0.21 mmol, 8%) as a colorless 
oil, Rf 0.20. trans-37: IR v 1735,1700, 690; JH NMR (200 MHz) 8  1.51 (s, 3 H, CH3), 2.35 (br s, 2 H, 
H4), 2.86 (d, J  = 13.5 Hz, 1 H, H6), 3.20 (d, J  - 13.5 Hz, 1 H, H6), 3.76 (s, 3 H, C02CH3), 4.30 (d, J =
14.0 Hz, 1 H, CWHPh), 4.41 (d, J  = 14.0 Hz, 1 H, CHffPh), 4.63-4.65 (m, 2 H, O O ty , 4.70-4.90 (m, 1 
H, H3), 5.22-5.36 (m, 2 H, =CH2), 5.68-6.05 (m, 1 H. =CH), 7.26-7.40 (m, 5 H, ArH); 13C NMR (50 
MHz) 8  30.6 (CH3), 40.0 (C4), 52.3 (CC^Oty, 52.5 (C3), 60.2 (CH2Ph), 66.8 (OCH^, 118.3 (=CH2),
127.8.128.2, 129.2 (ArH), 132.2 (=CH), 137.7 (ArC); MS (El. 70 eV) mlz (relative intensity) 366 (M+, 6), 
331 (14), 281 (8), 231 (5), 160 (41). 91 (100); HRMS ealed for C18H23N2 0 4a  366.1346, found 366.1318. 
c»'j-37: %  NMR (300 MHz) 8  1.30 (s, 3 H, CH3), 2.06 (dd, J  = 14.6, 7.2 Hz, 1 H, H4), 2.86-2.88 (m, 2 
H, H4 and H6), 3.02 (d, J  « 14.7 Hz, 1 H, H6), 3.82 (s, 3 H, C02CH3), 4.01 (d, J =13.0 Hz, 1 H, 
CtfHPh), 4.10 (d, J  = 13.0 Hz, 1 H, CHWPh), 4.15-4.90 (m, 3 H, OCH2  and H3), 4.95-5.40 (m, 2 H, 
=CH2), 5.92-6.03 (m, 1 H, =CH), 7.20-7.52 (tn, 5 H, ArH); 13C NMR (50 MHz) 8 30.8 (CH3), 40.0 (C4),
52.3 (C0 2 CH3), 57.9 (CH2Ph), 59.6 (C6), 59.7 (C3), 6 3 .0  (C5), 67.0 (OCH2), 117.6 (=CH2), 127.2,
128.2, 129.6 (ArH), 132.5 (=CH), 138.1 (ArC), 172.6 (C(0)). trans-36: IR v 1745, 1685, 690; %  NMR 
(200 MHz) 8 1.43 (s, 3 H, CH3), 2.19 (dd, /  = 13.2 Hz, 10.6 Hz, 1 H, H4), 2.88 (dd, J  = 13.2,8.9 Hz, 1H, 
H4), 3.18 (d, /=  11.3 Hz, 1 H, CffHCl), 3.37 (d ,/=  11.3,1 H, CH//C1), 3.82 (s, 3 H, C02CH3), 4.00(d, 
J=  13.2 Hz, 1 H, CHHPh), 4.11 (d, J  = 13.2 Hz, 1 H, NCHWPh), 4.41-4.55 (m, 3 H.H3 and OCH2), 5.10- 
5.23 (m, 2 H, =CH2), 5.55-5.80 (m, 1 H, =CH), 7.22-7.53 (m, 5 H, ArH); 13C NMR (63 MHz) 8  19.7 
(CH3), 37.1 (C4), 49.2 (CH2Q ), 52.5 (C02CH3), 58.1 (CH2Ph), 59.6 (C3), 66.4 (C9), 69.3 (C5), 118.2 
(=CH2), 127.0,128.0,129.4 (ArH), 132.3 (-CH), 138.0 (ArC). 172.6 (C(0)); MS (El, 70 eV) mlz (relative 
intensity) 366 (M+, 45), 331 (31), 317 (14), 281 (18), 231 (31), 91 (100); HRMS ealed for C ^H ^^C ^C l 
366.1346, found 366.1381. cis-36 : IR V 1745,1685,690; JH NMR (200 MHz) 8  1.27 (s, 3 H. CH3), 2.37- 
2.43 (m, 2 H, 2 x H4), 3.51 (d,7= 11.2 Hz, 1 H, CHHC1), 3.76 (d,7= 11.2 Hz, 1 H, CHffCl), 3.79 (s, 3 
H, C02CH3), 3.96 (s, 2 H. CW2Ph), 4.25-4.45 (m, 2 H, OCH2), 4.50-4.70 (m, 1 H, H3), 5.09-5.21 (m, 2 
H, =CH2), 5.55-5.80 (m, 1 H, =CH), 7.24-7.49 (m, 5 H, ArH); JH NMR (250 MHz, 50 ‘Q  81.25 (s, 3 H, 
CH3), 2.30-2.44 (m, 2 H, 2 x H4), 3.47 (d, J  = 11.3 Hz, 1 H, CHHC1), 3.73 (d, J - 11.3 Hz, 1H, CHWC1), 
3.78 (s, 3 H, C02 CH3), 3.97 (s, 2 H, CH2Ph), 4.25-4.45 (ra. 2 H, OCH2), 4.57 (dd, J  = 9.1, 7.7 Hz, 1 H, 
H3), 5.08-5.20 (m, 2 H, =CH2), 5.60-5.80 (m, 1 H, =CH), 7.18-7.47 (m, 5 H, ArH); 13C NMR (50 MHz) 8
22.3 (CH3), 38.4 (C4), 48.8 (CH2C1), 52.5 (C02CH3), 56.9 (CH2Ph), 59.5 (C3), 66.3 (OCH2), 68.4 (C5), 
117.4 (=CH2), 127.2, 128.0, 129.6 (ArH), 132.4 (=CH), 137.3 (ArC), 173.1 (C(0)); MS (El, 70 eV) m h  
(relative intensity) 366 (M+, 6 8), 331 (10), 317 (20), 307 (6). 281 (35), 255 (9), 231 (59), 91 (100); HRMS 
calcdforC18H23N204Cl 366.1346, found 366.1387.
re/-(3S,5S)-2*(Allyloxycarbonyl)-l-benzyI*5-formyloxy-5-methylhexahydro-3^ 
pyridazinecarboxylic acid methyl ester (38). A solution of 25 (565 mg, 1.45 mmol) in HCOOH (15 
mL) was stirred for 18 h at rt. Concentration in vacuo and fc (ethyl acetate/hexane 1:4) afforded 38 (369 mg,
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0.98 mmol, 6 8%) as a colorless oil, R f  0.30. IR v 1740, 1700, 690; !H NMR (200 MHz) 8  1.51 (s, 3 H, 
CH3), 2.20-2.40 (m, 1 H, H4), 2.40-2.60 (m, 1 H, H4), 2.87 (d,/ »  13.7 Hz, 1 H, H6), 3.38 (d, 13.7 
Hz, 1 H, H6 ), 3.74 (s, 3 H, CO2CH3), 4.20 (d, J  - 13.7 Hz, 1 H, CW2Ph), 4.27 (d, J-  13.7 Hz, 1 H, 
CH2Ph), 4.64 (d, 7- 5.5 Hz, 2 H, OCH2 and br s, 1 H, H3), 5.22-5.36 (m, 2 H, =CH2), 5.80-6.05 (m, 1 
H, =CH), 7.22-7.33 (m, 5 H, ArH), 7.91 (s, 1 H, CHO); 13C NMR (50 MHz) 8 24.4 (CH3), 34.9 (C4), 52.2 
(CC^Oty, 54.5 (C3), 56.7 (CH2Ph), 61.0 (C6), 66 .6  (OCH^, 79.4 (C5), 118.1 (=CH2), 127.3, 128.1,
128.9 (ArH), 132.2 (=CH), 137.6 (ArC), 157.0, 159.7, 172.0 (3 x C(O)); MS (El, 70 eV) mlz (relative 
intensity) 376 (M+, 43), 331 (14), 317 (7), 259 (13), 245 (26), 91 (100); HRMS calcd for C ig H ^ N ^ Q  
376.1634, found 376.1609.
re/-(3S,4S)-2-(AllyIoxycarbonyI)-l*benzyM-(l-chIoromethyIethyl)-3-pyrazolidinecarboxylic 
acid methyl ester (39). Following the general procedure C, a solution of 26 (140 mg, 0.35 mmol) in 
CH2Q 2 (4 mL) was treated with SnCl^  (0.58 mL of a 1.2 M soludon, 0.70 mmol). Work-up and fc (ethyl 
acetatetfiexane 1:4) afforded39 (76 mg, 0.20 mmol, 58%) as a colorless oil, 0.25. IR v 1735,1690,690; 1 
H NMR (200 MHz) 5 1.54 (s, 3 H, CH3), 1.66 (s, 3 H, CH3), 3.13-3.28 (m, 3 H, H4 and 2 x H5), 3.81 (d, 
J  * 12.5 Hz, 1 H, CffHPh), 3.82 (s, 3 H, CC^Oty, 4.17 (d, J  » 12.5 Hz, 1 H, CHtfPh), 4.56 (d, J  - 5.3 
Hz, 2 H, OCH2), 4.70 (d, /=  6.2 Hz, 1 H, H3), 5.15-5.31 (m, 2 H, »CH2), 5.70-5.95 (m, 1 H, ~CH), 
7.26-7.44 (m, 5 H, ArH); 13C NMR (50 MHz) 8  31.5, 31.9 (2 x CH3), 52.7 (C02CH3), 54.9 (C5), 55.8 
(C4), 61.9 (CH2Ph), 62.6 (C3), 66.5 (OCH^), 69.4 (CC1), 117.6 (=CH2), 127.5,128.2, 129.4 (ArH), 132.3 
(=CH), 137.2 (AxC), 173.4 (C(0)); MS (El, 70 eV) m il (relative intensity) 380 (M+, 67), 344 (36), 295 (44), 
245 (51), 91 (100); HRMS calcd for C ^ ^ N ^ C l  380.1503, found 380.1548.
re/-(35t45)-2-(aHyloxycarbonyl)"l-benzyl-4-[la>(formyIoxy)-l-methylethyl)-3«> 
pyrazolidinecarboxylic acid methyl ester (40). A solution of 26 (173 mg, 0.43 mmol) in HCOOH (5 
mL) was stirred at rt for 18 h. Concentration in vacuo and fc (ethyl acctate/hcxane 1:4) afforded 40 (110 mg, 
0.28 mmol, 6 6%) as a colorless oil, R f  0.25.  IR v 1735, 1715,1690, 690; %  NMR (200 MHz) 8 1.53 (s, 3 
H, CH3), 1.61 (s, 3 H, CH3), 3.06 (d, J - 8.7 Hz, 2 H, 2 x H5), 3.26-3.39 (m, 1 H, H4), 3.81 (s, 3 H, 
CQ2CH3), 3.82 (d, J  - 12.3 Hz, 1 H, CtfHPh), 4.20 (d, J  * 12.3 Hz, 1 H, CHWPh), 4.56 (d, J  = 5.5 Hz, 2 
H, OCH2), 4.62 (d, J=  7.4 Hz, 1 H, H3), 5.16-5.32 (m, 2 H, =CH2), 5.75-5.95 (m, 1 H, =CH), 7.27-7.43 
(m, 5 H, ArH), 7.93 (s, 1 H, OCHO); 13C NMR (50 MHz) 8 24.2, 25.0 (2 x CH3), 52.6 (C02CH3), 53.3 
(C5), 53.7 (C4), 61.3 (C3), 61.7 (CH2Ph), 66.5 (OCH2), 81.6 (CO), 117.7 (=CH2), 127.4, 128.2, 129.4 
(ArH), 132.3 (=CH), 137.1 (ArC), 159.8,173.2 (2 x C(0)); MS (El, 70 eV) mlz (relative intensity) 390 (M+, 
34), 345 (6), 227 (20), 91 (100); HRMS calcd for C2oH26N20 6 390.1791, found 390.1749.
r*/-(3S,4S)-2-(AIIyIoxycarbonyl)*l-benzyl-4-(l-chloroethyl)-3«pyrazolidinecarboxylic acid 
methyl ester (41), According to the general procedure C, a solution of 27 (513 mg, 1.32 mmol) in CH2C12 
(15 mL) was treated with SnCl4  (2.19 mL of a 1,2 M solution, 2.63 mmol). Work-up and fc (ethyl 
acetatetfiexane 1:4) afforded 41 (267 mg, 0.73 mmol, 56%) as a colorless oil, 1:5 mixture of isomers, /?ƒ 0.30.
IR v 1740,1690, 690; lH NMR (250 MHz) 8 (mixture) 1.57 (d, J  - 6.4 Hz, 3 H, CH3), 3.05-3.17 (m, 3 H, 
H4 and 2 x H5), 3.72-3.82 (m, 1 H, CWHPh), 3.80 (s, 3 H, C02CH3), 4.16 (d, J=  12.4 Hz, 1 H, CHtfPh),
4.24-4.28 (m, 1 H, H3), 4.46-4.53 (m, 3 H, CHC1 and OCH2), 5.13-5.27 (m, 2 H, =CH2), 5.72-5.90 (m, 1 
H, =CH), 7.24-7.43 (m, 5 H, ArH); JH NMR (250 MHz, 50 ‘C) 8 1.56 (d, J = 6.7 Hz, 3 H, CH3), 3.05- 
3.18 (m, 3 H, H4 and 2 x H5), 3.76 (d, ƒ  « 12.3 Hz, 1 H, CtfHPh), 3.81 (s, 3 H, C02CH3), 4.19 (d, J =
12.5 Hz, 1 H, CHi/Ph), 4.25-4.27 (m, 1 H, H3), 4.48-4.50 (m, 1 H, CHC1), 4.55 (d, J = 5.5 Hz, 2 H, 
OCH^, 5.14-5.29 (m, 2 H, =CH2), 5.72-5.95 (m, 1 H, *CH), 7.22-7.43 (m, 5 H, ArH); 13C NMR (63 
MHz) 8 (mixture) 23.5, 24.1 (CH3), 51.5, 51.8 (C4), 52.5, 52,7 (C02CH3), 54.6, 55.3 (C5), 57.5, 56.8 
(CHC1), 61.7, 62.0 (CH2Ph), 63.2, 63.0 (C3), 66 .6 , 66.7 (OCH2), 117.7, 118.3 (=CH2), 127.5, 127.7,
128.3, 128.4, 129.5, 129.8 (ArH), 132.2, 132.3 (=CH), 137.1,137.2 (ArC), 154.2, 154.3, 172.4, 172.5 (2 
x C(O)); MS (El, 70 eV) mlz (relative intensity) 366 (M+, 38), 330 (6), 281 (21), 231 (24), 91 (100); HRMS 
calcd for C18H23N204C1366.1346, found 366.1369.
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2-(AllyloxycarbonyI)-l-benz:yl-4-[(chloromethyl)niethylene]-3-pyrazolidinecarboxylic acid 
methyl ester (42). According to the general procedure C, a solution of28 (660 mg, 1.70 mmol) in CH2O 2 
(17 mL) was treated with TÍCI4  (2.84 mL of a 1.2 M solution, 3.40 mmol). Work-up and fc (ethyl 
acetate/hexane 1:6) afforded 42 (280 mg, 0.77 mmol, 45%) as a yellowish oil, 1.2:1 mixture of two isomers, 
Rf 0.40. IR v 1740,1700, 690; *H NMR (200 MHz) 8  (one isomer) 2.61-2.75 (m, 1 H, CHHC1), 3.31 (dd, J  
= 6.4, 3.1 Hz, 1 H, CHtfCl), 3.55-4.00 (m, 2 H. 2 xH5), 3.71 (s, 3 H, C02CH3), 4.35 (d, J  = 13.4 Hz, 1 
H, CHHPh), 4.47 (d, J  = 13.4 Hz, 1 H, CHtfPh), 4.65 (m. 2 H. OCH2). 4.90 (dd, J  « 12.2, 5.4 Hz, 1 H. 
C=CH), 5.21-5.45 (m, 2 H, =CH2>. 5.56-5.60 (br s, 1 H, H3), 5.83-6.10 (m, 1 H, CH2=C/Z), 7.26-7.41 
(m, 5 H. ArH); (other isomer) 2.61-2.75 (m, 1 H, CtfHCl), 3.25 (dd. J  * 6.5, 3.1 Hz, 1 H. CHtfCl), 3.55-
4.00 (m, 2 H. 2 x H5), 3.71 (s, 3 H, C02CH3), 4.11 (d, /=  13.4 Hz, 1 H, CWHPh), 4.46 (d, J  * 13.4 Hz, 1 
H, CHflPh), 4.77 (d, 5.7 Hz, 2 H, OCH2), 5.05 (dd, J  = 12.6,5.4 Hz, 1H. C=CH), 5.21-5.45 (m, 2 H. 
=CH2), 5.56-5.60 (be s, 1 H, H3), 5.83-6.10 (m, 1 H, CH2«Ctf), 7.26-7.41 (m. 5 H, ArH); 13C NMR (50 
MHz) 8  (mixture) 36.5, 36.6 (CH2C1). 51.2. 51.8 (C5), 52.4, 52.5 (C02CH3), 59.9, 60.9 (CH2Ph). 60.8,
61.1 (C3), 6 6 .1, 66.9 (OCH2), 117.3, 118.5 (*CH2), 124.9. 125.7 (G=CH), 127.0, 127.3 (C4), 127.5,
128.4,128.9 (ArH), 132.3, 132.4 (CH2=CH), 138.2, 138.3 (ArC). 154.5,171.3, 171.4 (2 X  C(0)); MS (El, 
70 eV). mil (relative intensity) 364 (M+. 6). 329 (25), 305 (11), 273 (42), 193 (21), 91 (100); HRMS ealed for 
c 18H21N2°4a  364.1190, found 364.1159.
2-(AIIyloxycarbonyl)-l-benzyl-5-chloro-ltf-l,2-diazepine-3"Carboxyiic acid methyl ester
(43). Following the general procedure C, a solution of 29 (279 mg, 0.72 mmol) in CH2Q 2 & was 
treated with SnCl4  (1.19 mL of a 1.2 M solution, 1.43 mmol). Work-up and fc (ethyl acetate/hexane 1:4) 
afforded 43 (170 mg, 0.46 mmol, 65%) as a colorless oil, 1:1 mixture of isomers, R f  0.25. IR v 1745, 1685, 
690; LH NMR (200 MHz) 8  (mixture) 1.50-1.75 (m, 2 H, 2 x H6), 2.23 (dd, J  = 12.7, 9.0 Hz, 1 H, H4), 
2.61 (ddd, J  =» 13.0, 9.2, 7.2 Hz, 1 H, H4), 3.15-3.50 (m, 3 H, 2 x H7 and H5), 3.73 (d, J  = 12.4 Hz, 1 H, 
CtfHPh), 3.81 (s, 3 H. C02CH3), 4.17 (d, J  - 12.4 Hz, 1 H, CHtfPh), 4.48-4.67 (m. 3 H, OCH2and H3). 
5.18-5.33 (m, 2 H, *CH2), 5.77-5.94 (m, 1 H, =CH), 7.26-7.44 (m, 5 H, ArH); 13C NMR (50 MHz) 8 
(mixture) 30.4, 34.3, 35.9, 36.0 (C4 and C6), 41.9 (C7), 52.6 (C02CH3), 59.6 (C3), 59.2, 61.2 (C5), 61.6 
(CH2Ph), 66.3 (OCH2). 117.5 (=CH2), 127.3, 128.1, 129.5 (ArH), 132.2 (=CH). 137.0 (ArC), 172.7 
(C(O)); MS (El. 70 eV) mlz (relative intensity) 366 (M+, 52), 325 (9), 303 (6). 275 (23), 91 (100).
2-(AIIyloxycarbonyl)-3-benzyM,2,3,4-tetr&hydro*l»phthalazinecarboxylic acid methyl ester
(44), According to the general procedure C, a solution of 30 (2.00 g, 4.69 mmol) in CH2CI2 (45 mL) was 
treated with SnCl4  (7.82 mL of a 1.2 M solution, 9.38 mmol). Work-up and fc (ethyl acetate/hexane 1:4) 
afforded 44 (1.55 mg, 4.23 mmol, 91%) as a colorless oil, R* 0.30. IR v 1740,1685,1400,690; !H NMR 8 
3.65-3.75 (m, 2  H. NCH2), 3.78 (br s. 3 H, C02CH3), 3.95-4.20 (m, 1 H. CtfHPh). 4.45-4.70 (m. 3 H, 
OCH2 and CHffPh), 5.15-5.40 (m. 2 H, =CH2), 5.63 (br s, 1 H. NCH), 5.80-6.05 (m, 1 H, =CH), 7.00- 
7.50 (m, 9 H. ArH); 13C NMR (50 MHz) 8  51.5 (NCH), 52.6 (CC>2CH3), 57.7 (NCH2), 59.3 (CH2Ph),
66.7 (OCH2), 117.9 (=CH2), 118.6, 127.1, 127.5,128.3, 128.8, 129.3 (ArH), 132.5 (=CH), 134.0, 135.1,
137.0 (ArC). 171.0 (C(0)); MS (El, 70 eV) mlz (relative intensity) 366 (M+, 32), 307 (15). 226 (32), 105 
(100), 91 (100); HRMS ealed for C21H22N20 4  366.1580, found 366.1579.
2-(Allyloxycarbonyl)*l-benzyl-5-methylenehexahydro-3-pyridazinecarboxylic acid methyl 
ester (45), According to the general procedure C, a solution of 31 (1.10 g, 2.38 mmol) in CH2CI2 (25 mL) 
was treated with Et2AlCl (5.95 mL of a 1.0 M solution, 5.95 mmol). Work-up and fc (ethyl acetate/hexane 1:4) 
afforded 45 (517 mg, 1.57 mmol, 83% (after correction)) as a colorless oil,/?ƒ 0.35. IR v 1735,1680,690; 
NMR (200 MHz) 8 2.59-2.70 (m, 1 H, H4), 3.01 (d, ƒ  =* 14.1 Hz, 1 H, H4), 3.20 (m, 1 H, H6), 3.40 (d,/*=
14.3 Hz, 1 H, H6), 3.75 (s, 3 H, C02CH3), 3.86 (d, J * 12.5 Hz, 1 H, C/ZHPh), 4.05 (d, J * 12.5 Hz, 1 H, 
CH/fPh), 4.62-4.80 (m, 2 H, OCH2). 4.88 (s, 1 H, C=CffH), 5.05 (m, 1 H, H3), 5.15 (s, 1 H, C=CHtf),
5.24-5.43 (m, 2 H, CH=C«2), 5.96-6.04 (m, 1 H, =CH), 7.23-7.40 (m, 5 H, ArH); *H NMR (250 MHz, 50 
*C) 8 2.64 (dd, J =  14.2, 7.4 Hz. 1 H. H4). 2.96 (dd, J  =  14.2, 3.3 Hz, 1 H, H4), 3.21 (d, J  =  14.5 Hz, 1 H,
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H6), 3.42 (d, J  «  14.5 Hz, 1H, H6), 3.73 (s, 3 H, C02CH3), 3.91 (d, J  * 12.5 Hz, 1 H, CHHPh), 4.08 (d, 
J=  12.5 Hz, 1 H, NCHHPh), 4.65-4.80 (m, 2 H, OCH2), 4.84 (s, 1 H, C*CHH), 4.97 (br s, 1H, H3), 5.10 
(s, 1 H, OCHA/), 5.22-5.40 (m, 2 H, CH«CH2), 5.91-6.07 (m, 1 H, =CH), 7.20-7.39 (m, 5 H, ArH); 13C 
NMR (50 MHz) 5 32.0 (C4), 52.2 (C02CH3), 53.9 (C6), 55.5 (C3), 57.9 (CH2Ph), 66 .6  (lOCHy), 91.5 
(C5), 113.7 (&=£%), 117.6 (CH=CH2), 127.2, 128.1, 129.0 (ArH), 132.5 (**CH), 137.4 (ArC), 172.0 
(C(0)); MS (El, 70 eV) mlz (relative intensity) 330 (M+, 46), 271 (24), 245 (44), 195 (20), 185 (24), 159
(69), 142 (29), 135 (42), 91 (100); HRMS ealed for C18H22N204  330.1580, found 330.1548.
re/- (35,55 )-2-(allyloxycarbonyl)-l-benzyl-5-methyl-5-(trifI uoroacetoxy)hexahydro-3- 
pyridazinecarboxylic acid methyl ester (46). A solution of 31 (232 mg, 0.50 mmol) in CH2Q 2 $  It^ j) 
was treated with CF3CO2H (155 pL, ZOO mmol) at 0 *G After being stirred at rt for 18 h, the mixture was 
poured into aq satd NaHCOj (25 mL) and extracted with CH2Q 2  (3 x 15 mL), The combined organic layers 
were dried (MgSO^), filtered, concentrated in vacuo and chromatographed (ethyl acetate/hexane 1:4) to afford 
46 (155. mg, 0.35 mmol, 70%) as a light yellow oil, R f  0.35. IR v 1775, 1735, 1710, 690; XH NMR (200 
MHz) 8 1.54 (s, 3 H, CH3), 2.30-2.55 (m, 2 H, 2 x H4), 2.89 (d,/ =  13.7 Hz, 1H, H6 ), 3.39 (d,/ -  13.7 
Hz, 1 H, H6), 3.76 (s, 3 H, C02CH3), 4.27 (s, 2 H, CH2Ph), 4.65 (d, 5.5 Hz, 2 H, OCHj), 4.75-4.95 
(m, 1 H, H3), 5.24-5.37 (m, 2 H, =CH2), 5.80-6.05 (m, 1 H, =CH), 7.26-7.34 (m, 5 H, ArH); MS (El, 70 
eV) mlz (relative intensity) 444 (M+, 8), 348 (13), 277 (8), 263 (7), 245 (10), 160 (42), 121 (29), 91 (100); 
HRMS ealed for C2 0H23N2O6F3 444.1508, found 444.1543.
2~(AlIyloxycarbonyI)-l-benzyl-4»ethenylidene*3"pyrazolid]necarboxylic acid methyl ester 
(47). To a solution of 32 (250 mg, 0.53 mmol) in CH2CI2 (25 mL) was added at 0 *C BF3*OEt2 (0.40 mL, 
3.15 mmol) and the mixture was stirred at 0 *C for 15 min. After stirring at rt for 4 h, the mixture was poured 
into aq satd NaCl (100 mL) and extracted with CH2CI2 (3 x 50 mL). The combined organic layers were dried 
(MgSC>4)t filtered, concentrated in vacuo and chromatographed (ethyl acetate/hexane 1:5) to afford 47 (51 mg, 
0.16 mmol, 30% (after correction)) as a light yellow oil, R f  0.20. IR v 1950,1745, 1685,690; %  NMR (200 
MHz) 8  3.65 (m, 2 H, 2 x H5), 3.81 (s, 3 H, C02CH3), 3.83 (d, J  «  12.4 Hz, 1 H, CHHPh), 4.10 (d, J  =
12.4 Hz, 1 H, CHHPh), 4.59 (d, J  - 5.5 Hz, 2 H, OCH2), 4.65-4.75 (m, 1 H, H3), 5.08-5.11 (m, 2 H. 
C=CH2), 5.18-5.34 (m, 2 H, CH=CH2), 5.77-5.97 (m, 1 H, =CH), 7.28-7.46 (m, 5 H, ArH); 13C NMR (50 
MHz) 8 52.6 (C02CH3), 55.5 (C5), 61.3 (C3), 61.8 (CH2Ph), 66 .6  (OCH2), 81.1 (C=CH2), 99.0 (C4),
117.9 (CH=CH2), 127.6,128.3,129.7 (ArH), 132.3 (=CH), 136.8 (ArC), 169.6 (C(O)), 200.3 (C=OCH2); 
MS (El, 70 eV) mlz (relative intensity) 328 (M+, 53), 243 (18), 193 (11), 124 (6), 91 (100); HRMS ealed for
C18H20N2°4 328.1423, found 328.1401.
rei-(3ilJ45,5S)-2-(Allyloxycarbonyl)*l-benzyl-5'*(chloromethyl)-4«(trimethyl8ilyl)-3- 
pyrazolidinecarboxylic acid methyl ester (48). According to the general procedure C, a solution of 33 
(925 mg, 2.06 mmol) in CH2CI2 (25 mL) was treated with SnCl4 (3.44 mL of a 1.2 M solution, 4,13 mmol). 
Work-up and fc (ethyl acetate/hexane 1:4) afforded 48 (591 mg, 1.39 mmol, 68%) as a colorless oil, Rf 0.45. 
IR v 1735,1685,1250,940,690; *H NMR (200 MHz) 8 0.12 (s, 9 H, (CH3)3Si), 2.00 (t, /-  9.1 Hz, 1 H, 
H4), 3.07 (dd,/ =  11.5, 4.3 Hz, 1 H, CHHC1), 3.25 (dd, ƒ=  11.5, 3.4 Hz. 1 H, CHHC1), 3.47-3.56 (m, 1
H, H5), 3.78 (s, 3 H, C02CH3), 3.99 (d,/= 12.8 Hz, 1 H, CHHPh), 4.36 (d,/ «  12.7 Hz, 1 H, CHHPh), 
4.56 (ddt, 7- 13.6, 5.3, 1.4 Hz, 1 H, OCHH), 4.67 (ddt, J  = 13.6, 5.3, 1.4Hz, 1 H, OCHH), 5.01 (d, J  =
9.0 Hz, 1 H, H3), 5.18-5.40 (m, 2 H, =CH2), 5.91-5.98 (m, 1 H, =CH), 7.26-7.51 (ArH); 13C NMR (63 
MHz) 8 1.5 (CH3)3Si), 35.3 (C4), 47.7 (CH2C1), 52.1 (C02CH3), 62.4 (C3), 63.4 (CH2Ph), 66.5 (OCH2).
68.8 (C5), 117.4 (-CH2), 127.5, 128.2, 129.4 (ArH), 132.6 (-CH), 137.8 (ArC), 156.0,172.3 (2 x C(0)); 
MS (El, 70 eV) mlz (relative intensity) 424 (M+, 57), 409 (10), 339 (13), 289 (10), 243 (20), 185 (23), 91 
(100); HRMS ealed for C y jH ^N ^C lS i 424.1585, found 424.1569.
2-(Aliyloxycarbonyl)-l-benzyl-l,2,3,6-tetrahydro-3-pyridazinecarboxylic acid methyl ester 
(49). According to the general procedure C, a solution of 34 (500 mg, 1.12 mmol) in CH2CI2 (12 mL) was
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treated with S/1CI4  (1.86 mL of a 1.2 M solution, 2.23 mmol). Work-up and fc (ethyl aeetate/hexane 1:4) 
afforded 48 (152 mg, 0.36 mmol, 32%) as a colorless oil, R f  0.45 and 49 (176 mg, 0.56 mmol, 50%) as a 
colorless oil, R t  0.25. 49: IR V 1740,1680,1400,985, 690; *H NMR (250 MHz) 8  3.09 (dd, J  -  17.6,4.2 
Hz, 1 H, H6), 3.46 (br d, J  - 19.3 Hz, 1 H, H6), 3.78 (g, 3 H, C02CH3), 3.82 (d. J  - 12.5 Hz, 1 H, 
CHHPh), 4.22 (d,/ =  12.5 Hz, 1 H, CHHPh), 4.60-4.80 (m. 2  H, OCH2), 5.10 (br s, 1 H, H3), 5.23-5.45 
(m, 2 H, -CHj), 5.65-6.15 (m, 3 H, CH2=CH, H4 and H5), 7.22-7.39 (m, 5 H, ArH); 13C NMR (63 MHz) 
546.9 (C6), 52.4 (C02CH3), 52.5 (C3), 59.3 (CH2Ph), 66.6 (OCH2), 117.6 (=CH2). 121.0,124.6 (C4 and 
C5), 127.3, 127.5, 128.0 (ArH), 132.7 (CH2=CH), 138.0 (ArC), 155.0, 170.2 (2 x C(0)); MS (El, 70 eV) 
mlz (relative intensity) 316 (M+, 10), 257 (10), 231 (13), 171 (14), 91 (100), 41 (43); HRMS ealed for
C17H20N2°4316-1423*found 316.1401.
ri/'’(3S,5JO-2»(AllyIoxycarbonyl)-l-benzy]-5'methyl-3-pyr&zolidinecarboxy]ic acid methyl 
ester (56). To a refluxing solution of «-Bu3SnH (160 mL, 0.60 mmol) in benzene (2 mL) was added 
dropwise in 1 h a solution of 35 (55 mg, 0.15 mmol) and AIBN (5 mg, 0.030 mmol) in benzene (2 mL). After 
refluxing for 18 h, the solution was concentrated in vacuo and chromatographed (hexane, then ethyl 
acetate/hexane 1:4) to afford 56 (31 mg, 0.097 mmol, 65%) as a colorless oil, R f  0.25. IR V 1740,680,1400, 
690; !H NMR (200 MHz) 5 0.98 (d, ƒ  * 7.1 Hz, 3 H, CH3), 2.18 (dd. J  = 12.5, 8.7 Hz, 1 H, H4), 2.45-2.60 
(m, 1 H, H4), 3.37 (quintet, J  «  6.6 . Hz, 1 H, H5), 3.74 (d, J  - 12.8 Hz, 1 H, CHHPh), 3.80 (s, 3 H, 
CO2CH3), 4.17 (d, J  * 12.8 Hz, 1 H, CHHPh), 4.57 (d, J  - 5.5 Hz, 2 H, OCH2), 4.59 (t, J  * 8.9 Hz, 1 H, 
H3), 5.14-5.32 (m, 2 H, =CH2), 5.76-5.95 (m, 1 H, =CH), 7.23-7.47 (m, 5 H, ArH); l3C NMR (50 MHz) 8
19.9 (CH3), 35.4 (C4), 52.5 (C02CH3), 58.6, 59.5 (2 x NCH), 61.5 (CH2Ph), 66.3 (OCH2), 117.2 
(=CH2), 127.3,128.2, 129.4 (ArH), 132.7 (=CH), 137.8 (ArC), 173.2 (C(O)).
2»(AIIyloxycarbonyI)*l-benzy]-5,5-diniethyI-3-pyrazolidinecarboxylic acid methyl ester (57). 
To a refluxing solution of n-Bu3SnH (217 ^L, 0.82 mmol) in benzene (2 mL) was added dropwise in 1 h a 
solution of 36 (75 mg, 0.20 mmol) and AIBN (3.4 mg, 0.02 mmol) in benzene (2 mL). After refluxing for 18 
h, the solution was concentrated in vacuo and chromatographed (hexane, then ethyl acetate/hexane 1:4) to afford 
57 (35 mg, 0.11 mmol, 51%) as a colorless oil, R f  0.15. IR v 1740,1680, 690; *H NMR (200 MHz) 8  1.20-
1.30 (s, 6  H, (CH3 )2C), 2.30 (d, 7= 9.2 Hz, 2  H, 2 x H4), 3.80 (s, 3 H, C02CH3), 3.85 (d,/= 12.4 Hz. 1 
H. CHHPh), 3.99 (d, /=  12.4 Hz, 1 H, CHHPh). 4.10-4.45 (m, 2 H. OCH2), 4.60 (t, J-  9.3 Hz, 1 H, H3), 
5.05-5.17 (m, 2 H, =CH2), 5.55 (m, 1 H, =CH), 7.17-7.54 (m, 5 H, ArH).
re/-(3S,4S)-2-(AllyIoxycarbonyl)-l-benzyI-4-ethyl-3*pyrazolidinecarboxylic acid methyl 
ester (58). To a refluxing solution of K-Bu3SnH (324 |iL, 1.22 mmol) in benzene (2 mL) was added 
dropwise in 1 h a solution of 41 (112 mg, 0.31 mmol) and AIBN (5.0 mg, 0.030 mmol) in benzene (2 mL). 
After refluxing for 18 h, the solution was concentrated in vacuo, taken up in THF (10 mL) and stirred with KF 
(93 mg, 1.22 mmol) and TBAF (122 mL of a 1.0 M solution in THF, 0.12 mmol) for 17 h. The organic layer 
was dried (MgSC^, filtered, concentrated in vacuo and chromatographed (ethyl acetate/hexane 1:4) to afford 5 8 
(39 mg, 0.12 mmol, 38%) as a colorless oil, Rf 0.25. IR V 1740, 1685, 690; *H NMR (200 MHz) 8 0.94 (t, ƒ
* 7.5 Hz, 3 H, CH2Ctf3), 1.40-1.55 (m, 1 H, CtfHCH3), 1.70-1.90 (m, 1 H, CHHCH3), 2.65-2.73 (m, 2 
H, 2  x H5), 3,15-3.18 (m, 1 H, H4), 3.82 (s, 3 H, C02CH3), 3.75-3.85 (m, 1 H, C//HPh), 4,05-4.25 (m, 2
H, CHHPh and H3), 4.53 (d, J = 5.4 Hz, 2 H, OCH2), 5.14-5.30 (m, 2 H, =CH2), 5.76-5.90 (m, 1 H, 
=CH), 7.23-7.46 (m, 5 H, ArH); 13C NMR (50 MHz) 5 12.2 (CH2CH3), 24.7 (CH2CH3), 45.5 (C4), 52.5 
(CO2CH3), 57.8 (C5), 61.7 (CH2Ph). 65.8 (C3), 66.5 (OCH2), 117.7 (=CH2), 127.4, 128.3, 129.6 (ArH),
132.5 (=CH), 137.4 (ArC), 173.1 (C(O)).
General procedure D for the transprotection reactions. To a solution of the Alloc compound and 
Boc20 (2 equiv) in CH2C12  was added Pd(PPh3)4 (0.02 equiv), immediately followed by the full amount of n- 
Bu3SnH (1.1 equiv) and the mixture was stirred at rt for 2 h. Concentration in vacuo and purification by fc (first 
with hexane, then with the suitable eluent) afforded the pure produces).
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re/-(3S,5S)-l-Benzyl-2-(ter/-butoxycarbonyl)-5-(chloromethyI)-3-pyrazoHdinecarboxyIic 
acid methyl ester (65)« Following the general procedure D, a solution of 35 (760 mg, 2.16 mmol) in 
CH2Q 2 (25 mL) was treated with B0C2O (990 nL, 4.31 mmol), Pd(PPh3)4 (50 mg, 0.043 mmol) and n- 
Bu3SnH (629 pL, 2.37 mmol). Concentration in vacuo and fc (ethyl acctate/hexane 1:4) afforded 65 (612 mg,
1.66 mmol, 77%) as a light yellow oil, Rf 035. IR v 1740,1680,1360,690; !H NMR (200 MHz) 5 1.43 (s,
9 H, (CH3)3), 2.47-2.69 (m, 2 H, 2 x H4), 3.11 (dd,/= 8.1, 10.6 Hz, 1 H, CWHC1), 3.30-3.44 (m, 2 H, 
CHHC1 andH5), 3.77 (d, ƒ=  12.6 Hz, 1 H, CWHPh), 3.81 (s. 3 H, C02CH3), 4.23 (d ./=  12.6 Hz, 1 H, 
CHtfPh), 4.59 (t, J  = 8.8 Hz, 1 H, H3), 7.27-7.47 (m, 5 H, ArH).
re/-(3J?,5S)-2-(/*r/-ButoxycarbonyI)-5-chloromethyl-3-pyrazoUdinecarboxylic acid methyl 
ester (6 6 ). A mixture of 65 (120 mg, 0.33 mmol), Pd/C (30 mg of 10% Pd on C, 0.03 mmol) and a few 
drops of a 1 M HCl/MeOH solution in MeOH (10 mL) was stirred under a H2-atmosphere for 1 h. After 
filtration over Celite, the solution was concentrated in vacuo, taken up in aq satd NaHCC^ (20 mL) and 
extracted with CH2 Cl2  (3 x 20 mL). The combined organic layers were dried (MgS0 4 ), filtered, concentrated 
in vacuo and chromatographed (ethyl acetate/hexane 1:1) to afford 6 6  (81 mg, 0.29 mmol, 90%) white solid, 
mp 45-47 -C, R f  0.15. IR V 1740, 1705* 1365, 1130; NMR (200 MHz) 8 1.45 (s, 9 H, (CH3)3C), 2.23 
(ddd, /  * 13.2, 7.1, 5.1 Hz, 1 H, H4), 2.54 (ddd, /  » 13.2, 9.2, 4.4 Hz, 1 H, H4), 3.43 (dd,/- 11.2, 7.3 
Hz, 1 H, C//HC1), 3.60 (dd, 11.2, 4.8 Hz, 1 H, CHtfCl), 3.75 (s, 3 H, CO2CH3), 3,66-3.77 (m, 1 H, 
H5), 4.59 (dd, J  = 4.9,9.1 Hz, 1 H, H3);13C NMR (50 MHz) S 28.3 ((CH3)3C), 35.7 (C4), 44.9 (CH2C1).
52.4 (C0 2 CH3), 59.0, 59.2 (C3 and C5), 81.1 ((CH3)3Q ; MS (El, 70 eV) mlz (relative intensity) 178 (M+- 
100,90), 119 (100), 95 (45), 91 (100), 69 (60).
Crystallographic data.
Tetragonal, P 42jc, a=b=  17.4709(7), c = 9.695 A, a  « /J = /=  90‘, V = 2959.3(2) A3, Z - 8 , Dx - 1.25 
gem'3, X(CuKa) *  1.5418 A, ji(CuKa) « 23.98 cm*1, F(000) - 1184, rt Final R = 0.076 for 1164 observed 
reflections.
Table 7.3. Bond distances of the atoms (A), with standard deviations in parentheses.
C1-C4 1.777(8) C7-N2 1.337(8) C2-H21 1.07(6) C9-H92 1.10(4)
ci-c2 1.553(9) C7-03 1.193(8) C2-H22 1.11(3) C9-H93 1.07a)
C1-H4 1.51(1) C7-04 1.366(7) C3-H3 1.06(4) C10-H101 1.09(5)
Cl-Nl 1.467(8) C8-C9 1.49(1) C4-H41 1.07(4) C10-H102 1.08(4)
C2-C3 1.548(9) C8-C10 1.52(1) C4-H42 1.08(6) C10-H103 1.08(4)
C3-C5 1.496(9) C8-C11 1.51(1) C6-H61 1.08(7) Cll-Hlll 1.10(3)
C3-N2 1.441(8) C4-08 1.489(8) C6-H62 1.10(4) C11-H112 1.09(4)
C5-01 1.2 1 (1) N1-N2 1.420(6) C6-H63 1.09(6) C11-H113 1.07(5)
C5-02
C6-02
1.306(9)
1.47(1)
Cl-HI 1.05(4) C9-H91 1.08(5) N1-H2 1.06(5)
Table 7.4. Bond angles of the atoms (*), with standard deviations in parentheses.
C2-C1-C4 113.6(5) C1-N1-N2 103.4(4) H61-C6-H63 90(5)
C2-C1-N1 104.4(5) C5-02-C6 114.5(6) H62-C6-H63 145(5)
C4-C1-N1 107.2(5) C7-04-C8 121.1(5) C8-C9-H91 100(3)
C1-C2-C3 103.0(5) C2-C1-H1 106(2) C8-C9-H92 99(4)
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C2-C3-C5 108.9(5) C4-C1-H1 111(3) C8-C9-H93 98(4)
C2-C3-N2 103.1(5) N1-C1-H1 115(2) H91-C9-H92 128(5)
C5-C3-N2 115.8(6) C1-C2-H21 97(4) H91-C9-H93 115(6)
C1-C4-C1 112.2(5) C1-C2-H22 107(3) H92-C9-H93 110(5)
C3-C5-01 121.5(7) C3-C2-H21 107(4) C8-C10-H101 99(3)
C3-C5-02 114.4(6) C3-C2-H22 113(3) C8-C10-H102 103(3)
01-C5-02 124.1(7) H21-C2-H22 126(5) C8-C10-H103 105(3)
N2-C7-03 126.4(6) C2-C3-H3 122(3) H101-C10-H102 115(4)
N2-C7-04 107.7(5) C5-C3-H3 106(2) H101-C10-H103 123(4)
03-C7-04 125.8(6) N2-C3-H3 101(3) H102-C10-H103 109(4)
C9-C8-C10 110.0(6) Q-C4-H41 94(3) C8-C11-H111 102(4)
C9-C8-C11 112.0 (6) G-C4-H42 118(4) C8-C11-H112 105(2)
C9-C8-04 109.0(5) C1-C4-H41 116(3) C8-C11-H113 115(3)
C10-C8-C11 113.0(6) C1-C4-H42 101(4) H111-C11-H112 110(5)
C10-C8-04 102.3(5) H41-C4-H42 118(5) H111-C11-H113 129(6)
Cl 1-C8-04 110.1(5) 02-C6-H61- 95(4) H112-C11-H113 94(4)
C3-N2-C7 126.5(5) 02-C6-H62 97(3) C1-N1-H2 107(4)
C3-N2-N1 114.3(4) 02-C6-H63 100(4) N2-N1-H2 108(4)
C7-N2-N1 118.9(5) H61-C6-H62 118(5)
re/-(3i?,55)-5-chIoromethyl-3-pyr«zoiidlnecarboxylic acid hydrogen chloride (67), A solution 
of 66  (30 rag, 0.11 mmol) in 2 M HC1 was heated at 60 "C for 2 h and concentrated in vacuo to afford 67 (18 
mg, 0.090 mmol, 82%) as a viscous yellow oil. !H NMR (200 MHz, D20) 6 2.46 (dt, J  = 13.8, 8.4 Hz, 1 H, 
H4), 2.67 (ddd, J  «  4.5, 7.8, 13.9 Hz, 1 H, H4), 3.74 (dd, /=  7.5, 12.4 Hz, 1 H, CffHCl), 3.90 (dd, /  = 
3.8, 12.3 Hz, 1 H, CH//C1), 4.08-4.20 (m, 1 H, H5), 4.49 (dd, J  = 4.4, 8.9 Hz, 1 H, H3); 13C NMR (50 
MHz, D20) 8  34.9 (C4), 44.8 (CH2C1), 62.4,62.6 (C3 and C5), 174.5 (C(0)).
re/-(35,4S)-l-Benzyl*2-(/er/-butoxycarbonyl)-4-(l-chIoroethyl)-3*pyrazolidinecarboxyllc 
acid methyl ester (6 8 ). According to the general procedure D, a solution of 41 (90 mg, 0.25 mmol) in 
CH2CI2 (3 mL) was treated with B0C2O (124 jiL, 0.54 mmol), Pd(PPh3)4 (8.5 mg, 7.4« 10” ^  mmol) and n- 
Bu3SnH (72 jiL, 0.27 mmol). Concentration in vacuo and flash chromatography (ethyl acetate/hexane 1:4) 
afforded 6 8  (49 mg, 0.13 mmol, 54%) as a light yellow oil, R ,  0.35. IR v 1745,1700, 1680, 690; XH NMR 
(200 MHz) 8 1.39 (s, 9 H, (CH3)3C), 1.56 (d, /  = 6.7 Hz, 3 H, CH3), 3.03-3.10 (m. 3 H, H4 and 2 x H5), 
3.69-3.85 (m, 2  H, Cff2p h ) . 3 -82 (s. 3 H* C02CH3), 4.15-4.30 (m, 2 H, H3 and CHC1), 7.26-7.46 (m, 5 H, 
ArH); 13C NMR (50 MHz) 8 24.1 (CH3), 28.2 ((CH3)3C), 51.5 (C4), 52.6 (C02CH3), 54.5 (C5), 57.5 
(CHC1), 61.8 (CH2Ph), 63.2 (C3), 81.0 ((CH3)3C), 127.4,128.3,129.6 (ArH). 137.5 (ArC), 172.9 (C(O)); 
MS (El, 70 eV) mlz (relative intensity) 382 (M+, 4), 281 (58), 245 (15), 231 (9), 91 (100); HRMS ealed for
C19H27N2°4C1 382.1659, found 382.1635.
l*Benzyl-2-(fer/-butoxycarbonyl)-5-chlorohexahydrQ-l//»diazeptiie"3~carboxyHc acid methyl 
ester (69). According to the general procedure D, a solution of 42 (76 mg, 0.21 mmol) in CH2CI2 (3 mL) 
was treated with B0C2O (105 HL, 0.46 mmol), Pd(PPh3)4 (7.2 mg, 6.2*10"^  mmol) and /i~Bu3SnH (60 \¡Lt 
0.23 mmol). Concentration in vacuo and fc (ethyl acetate/hexane 1:4) afforded 69 (51 mg, 0.13 mmol, 64%) as 
a colorless oil, R ,0.50. IR v 1740,1680, 690; ]H NMR (200 MHz) 8 1.38 (s, 9 H, (CH3)3C), 1.45-1.65 (m,
2 H, 2 x H6), 2.19 (dd, /=  12.8, 8.9 Hz, 1 H, H4), 2.59 (ddd, J  * 13.0,9.3,7.0 Hz, 1 H, H4), 3.20-3.55 
(m, 3 H, H5 and 2 x H7), 3.68 (d, J = 12.3 Hz, 1 H, CWHPh), 3.80 (s, 3 H, C02CH3), 4.13 (d, /=  13.0 
Hz, 1 H, CH/ZPh), 4.50 (t, J  = 8 .8  Hz, 1 H, H3), 7.22-7.44 (m, 5 H, ArH); 13C NMR (50 MHz) 8 (two 
diastereomers) 28.2 ((CH3)3C), 30.5, 34.4, 36.0, 35.9 (C4 and C6), 41.9 (C7), 52.4 (C02CH3), 59.5 (C3),
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60.2 (C5), 61.4 (CH2Ph), 80.6 ((CH3)3C), 127.3, 128.1, 129.8 (ArH), 137.6 (ArC), 173.4 (C(O)); MS (El, 
70 eV) mJz (relative intensity) 382 (M+, 3), 327 (20), 281 (58), 163 (10), 91 (100).
Deprotection of 44« Following the general procedure D, a solution of 44 (200 mg, 0.55 mmol) in CH2Q 2 
(3 mL) was treated with B0C2O (139 [iL, 0.61 mmol), Pd(PPh3)4 (13 mg, 0.011 mmol) and w-Bu3SnH (160 
M-L, 0.61 mmol). Concentration in vacuo and flash chromatography (ethyl acetate/hexane 1:4) ¿forded 3- 
benzyl-2-(ter/-butoxycarbonyl)-l,2,3,4-tetrahydro-l-phthalazinecarboxylic acid methyl ester
(70) (118 mgf 0.31 mmol, 56%) as a colorless oil, Rf 0,35 and 3-benzyI-3,4-dihydro-l- 
phthalazinecarboxylic acid methyl ester (71) (35 mg, 0.12 mmol, 22%) as a colorless oil, Rf 0.32, 70; 
IR v 1735, 1670, 1130, 690; NMR (200 MHz) 8 (some signals appear as rotamers) 1.52, 1.53 (s, 9 H, 
(Ctf3)3C), 3.30-4.50 (br m, 7 H, CO20H3, CHtfh and NCH2), 5.40, 5.60 (br s, 1 H, NCH), 7.00-7.50 
(m, 9 H, ArH); 13C NMR (63 MHz) 6 28.4 ((CH ^C ), 52.4 (CO2CH3), 52.8 (NCH), 55.6 (NCH2), 59.1 
(CH2Ph), 81.3 ((CH3)30 , 126.1, 127.4, 127.9, 128.3, 129.4, 131.7 (ArH), 132.0, 136.1, 138.0 (AiC),
171.5 (C(0)); MS OEI, 70 cV) mlz (relative intensity) 382 (M+, 20), 282 (61), 223 (45), 91 (100), 57 (83); 
HRMS ealed for C22H26N2O4  382.1892, found 382.1901. 71: IR v 1700, 1435, 1135, 690; !H NMR (200 
MHz) 8  3.94 (s, 3 H, C02CH3), 4.08 (s, 2 H, NCH2), 4.69 (s, 2 H, C//2Ph), 6.89-6.94 (m, 1 H, ArH), 
7.23-7.40 (m, 7 H, ArH), 8.08-8.13 (m, 1 H, ArH).
1-Benzyl»3-methylene-l,4,5,6-tetrahydrO"3-pyridazinecarboxyHc acid methyl ester (72).
According to the general procedure D, a solution of 45 (100 me, 0.30 mmol) in CH2C12 (3 mL) was treated 
with B0C2O (153 |iL, 0.67 mmol), Pd(PPh3)4 (11 mg, 9.1 •10"-’ mmol) and n-Bu3SnH (88 jlL, 0.33 mmol). 
Concentration in vacuo and flash chromatography (ethyl acetate/hexane 1:4) afforded 72 (58 mg, 0.24 mmol, 
78%) as a colorless oil, Rf 0.25. lH NMR (200 MHz) 5 3.14 (s, 2 H, 2 x H4), 3.43 (s, 2 H, 2 x H6), 3.84 (s,
3 H, C02CH3), 4.61 (s, 2 H, C//2Ph), 4,93 (s, 1 H, C^CtfH), 5.03 (s, 1 H, G*CHH), 7.24-7.35 (ro, 5 H, 
ArH).
re/-(3/i,4S>55)-l-Benzyl-2-(/er/-butoxycarbonyl)-5-(chIoromethyl)-4-(trimethylsilyl)«3- 
pyrazolidinecarboxylic acid methyl ester (73). Following the general procedure D, a solution of 48 
(434 mg, 1.02 mmol) in CH2 C12  (15 mL) was treated with B0C2O (0.52 mL, 2.25 mmol), Pd(PPh3)4 (35 mg, 
0.031 mmol) and fl-Bu3SnH (0.30 mL, 1.13 mmol). Concentration in vacuo and fc (ethyl acetate/hexane 1:4) 
afforded 73 (288 mg, 0.65 mmol, 64%) as a light yellow oil, R f  0.60. IR v 1760,1690, 1250, 840, 690; %  
NMR (200 MHz) 8  0.11 (s, 9 H, (CH3)3Si), 1.45 (s, 9 H, (CH3)3C), 1.97 (t, J  = 9.0 Hz, 1 H, H4), 3.06 
(dd, J = 11.4, 4.3 Hz, 1 H, CHHC1), 3.24 (dd, J  = 11.4, 3.4 Hz, 1 H, CHffCl), 3.43-3.50 (m, 1 H, H5),
3.77 (s, 3 H, CO2CH3), 3.96 (d, J=  12.7 Hz, 1 H, CHHPh), 4.32 (d, J  = 12.7 Hz. 1 H, CH/ZPh), 4.99 (d, 
J  = 9.0 Hz, 1 H, H3), 7.26-7.51 (m, 5 H, ArH); i3C NMR (50 MHz) 8  1.7 ((CH3)3Si), 28.3 ((CH3)3C),
35.1 (C4), 47.9 (CH2C1), 52.0 (C02CH3), 62.0 (C3), 63.2 (CH2Ph), 68.7 (C5), 80.8 ((CH3)3C), 127.4,
128.2,129.4 (ArH), 138.1 (ArC), 155.7, 172.8 (C(0)); MS (El, 70 eV) mlz (relative intensity) 440 (M+, 26), 
340 (90), 325 (12), 185 (13), 159 (5), 133 (8), 91 (100); HRMS ealed forC2 iH33N20 4ClSi 440.1898, found 
440.1905.
2-(/er/-Butoxycarbonyl)-5-chIorohexahydro-li/-diazepine-3-carboxylic acid methyl ester 
(74). A mixture of 69 (40 mg, 0.10 mmol), Pd/C (11 mg of 10% Pd on C, 0.01 mmol) and one drop of a 3 M 
HCl/MeOH solution in MeOH (5 mL) was stirred under a H2-atmosphere for 1 h. After filtration over Celite, 
the solution was concentrated in vacuo, taken up in aq satd NaHC03 (10 mL) and extracted with CH2C12 (3 x
10 mL). The combined organic layers were dried (MgS0 4 ), filtered, concentrated in vacuo and 
chromatographed (ethyl acetate/hexane 1:2) to afford 74 (20 mg, 0.065 mmol, 65%) as a colorless oil, Rf 0.25. 
IR v 3450, 1720, 1685; !H NMR (200 MHz) 8  1.45 (s. 9 H, (CH3)3), 1.69-1.84 (m, 2  H, 2 x H6), 2.19- 
2.27 (m, 2 H, 2 x H4), 3.53-3.78 (m, 3 H, H5 and 2  x H7), 3.75 (s, 3 H, C02CH3), 4.50-4.63 (m, 1 H, 
H3); 13C NMR (50 MHz) 8  (mixture of isomers) 28.0 ((CH3)3C), 30.5,35.6,35.8, 38.2,38.3 (C4 and C6),
42.0 (C7), 52.1 (C0 2CH3), 56.0, 56.5 (C5), 58.8 (C3), 80.9 ((CH3)3C), 172.7 (C(O)); MS (El, 70 eV) mlz
Cyclic a-hydrazino acid derivatives 8627
(relative intensity) 292 (M+, 6), 236 (8), 192 (20), 175 (13), 167 (23), 153 (27), 131 (100).
m
re/-(3X,4S,5S)-2-(l*r/»ButoxycarbonyI)-5-chIoroinethyl-4»(triinethyIsUyl)»3» 
pyrazolidinecarboxylic acid methyl ester (75). A mixture of73 (275 mg, 0.63 mmol), Pd/C (67 mg of 
10% Pd on C, 0.06 mmol) and a few drops of a 3 M HCI/MeOH solution in MeOH (7 mL) was stirred under a 
^-atmosphere for 45 min. After filtration over Celite, the solution was concentrated in vacuo, taken up in aq 
satd NaHCOj (10 mL) and extracted with CH2CI2  (3 x 10 mL). The combined organic layers were dried 
(MgSO^, filtered, concentrated in vacuo and chromatographed (ethyl acetate/hexane 1:2) to afford 75 (178 mg,
0.51 mmol, 81%) as a colorless oil, Rf 0.50. IR v 1735, 1700,1250, 840; JH NMR (200 MHz) 5 0.10 (s, 9
H, (CH3)3Si), 1.45 (s, 9 H, (CH3)3C), 1.84 (t, J  = 9.0 Hz, 1 H, H4), 3.57-3.84 (m, 6  H, C02CH3, H5 and 
CH2C1), 4.65 (d, J  - 8.8 Hz, 1 H, H3); 13C NMR (50 MHz) 8  1.7 ((CH3)3Si), 28.2 ((CH3)3C), 36.1 (C4),
45.2 (CH2C1), 51.8 (CO2CH3), 60.6 (C3), 63.0 (C5), 81.1 ((CH3)3Q , 153.2,172.0 (C(0)); MS (El, 70eV) 
mtz (relative intensity) 350 (M+, 8), 279 (9), 250 (100), 191 (47), 185 (19), 133 (18); HRMS ealed for 
c 14H27N2°4clSi 350.1429, found 350.1468. 
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